7Baggers

Abbott Laboratories
(NYSE:ABT) 

ABT stock logo

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmac...

Founded: 1888
Full Time Employees: 107,000
CEO: Robert Ford  
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 
                                                           
      net sales
    11,459,000,000 11,369,000,000 11,142,000,000 10,358,000,000 10,974,000,000 10,635,000,000 10,377,000,000 9,964,000,000 10,241,000,000 10,143,000,000 9,978,000,000 9,747,000,000 10,091,000,000 10,410,000,000 11,257,000,000 11,895,000,000 11,468,000,000 10,928,000,000 10,223,000,000 10,456,000,000 10,701,000,000 8,853,000,000 7,328,000,000 7,726,000,000 8,314,000,000 8,076,000,000 7,979,000,000 7,535,000,000 7,656,000,000 7,767,000,000 7,390,000,000 6,829,000,000 6,637,000,000 6,335,000,000 5,302,000,000 5,333,000,000 4,885,000,000 5,150,000,000 5,170,000,000 4,897,000,000 5,104,000,000 5,551,000,000 5,244,000,000 5,369,138,000 5,446,025,000 5,377,895,000 9,773,241,000 9,807,100,000 9,456,633,000 9,816,665,000 9,616,291,000 9,040,850,000 8,674,505,000 8,826,014,000 7,698,354,000 
      yoy
    4.42% 6.90% 7.37% 3.95% 7.16% 4.85% 4.00% 2.23% 1.49% -2.56% -11.36% -18.06% -12.01% -4.74% 10.11% 13.76% 7.17% 23.44% 39.51% 35.34% 28.71% 9.62% -8.16% 2.53% 8.59% 3.98% 7.97% 10.34% 15.35% 22.60% 39.38% 28.05% 35.86% 23.01% 2.55% 8.90% -4.29% -7.22% -1.41% -8.79% -6.28% 3.22% -46.34% -45.25% -42.41% -45.22% 1.63% 8.48% 9.02% 11.22% 24.91%     
      qoq
    0.79% 2.04% 7.57% -5.61% 3.19% 2.49% 4.14% -2.70% 0.97% 1.65% 2.37% -3.41% -3.06% -7.52% -5.36% 3.72% 4.94% 6.90% -2.23% -2.29% 20.87% 20.81% -5.15% -7.07% 2.95% 1.22% 5.89% -1.58% -1.43% 5.10% 8.21% 2.89% 4.77% 19.48% -0.58% 9.17% -5.15% -0.39% 5.57% -4.06% -8.05% 5.85% -2.33% -1.41% 1.27% -44.97% -0.35% 3.71% -3.67% 2.08% 6.36% 4.22% -1.72% 14.65%  
      cost of products sold, excluding amortization of intangible assets
    4,922,000,000 5,075,000,000 4,854,000,000 4,468,000,000 4,942,000,000 4,698,000,000 4,603,000,000 4,463,000,000 4,556,000,000 4,605,000,000 4,483,000,000 4,331,000,000 4,593,000,000 4,629,000,000 4,933,000,000 4,987,000,000 4,766,000,000 4,423,000,000 4,947,000,000 4,401,000,000 4,493,000,000 3,966,000,000 3,263,000,000 3,281,000,000 3,434,000,000 3,358,000,000 3,279,000,000 3,160,000,000 3,166,000,000 3,282,000,000 3,067,000,000 2,857,000,000 3,173,000,000 3,044,000,000 2,285,000,000 2,287,000,000 2,140,000,000 2,242,000,000 2,218,000,000 2,081,000,000 2,331,000,000 2,506,000,000 2,470,000,000             
      amortization of intangible assets
    422,000,000 420,000,000 420,000,000 420,000,000 465,000,000 470,000,000 471,000,000 472,000,000 481,000,000 496,000,000 498,000,000 491,000,000 496,000,000 498,000,000 507,000,000 512,000,000 514,000,000 520,000,000 504,000,000 509,000,000 508,000,000 510,000,000 553,000,000 561,000,000 483,000,000 484,000,000 483,000,000 486,000,000 544,000,000 562,000,000 584,000,000 501,000,000 392,000,000 522,000,000 140,000,000 145,000,000 144,000,000 151,000,000 151,000,000 156,000,000 132,000,000 161,000,000 174,000,000 196,697,000 196,892,000 199,422,000          
      research and development
    735,000,000 766,000,000 725,000,000 716,000,000 749,000,000 713,000,000 698,000,000 684,000,000 700,000,000 672,000,000 715,000,000 654,000,000 725,000,000 782,000,000 684,000,000 697,000,000 762,000,000 672,000,000 654,000,000 654,000,000 698,000,000 580,000,000 564,000,000 578,000,000 595,000,000 596,000,000 577,000,000 672,000,000 574,000,000 575,000,000 589,000,000 562,000,000 513,000,000 547,000,000 352,000,000 348,000,000 379,000,000 378,000,000 345,000,000 313,000,000 307,000,000 335,000,000 387,000,000 356,877,000 362,557,000 346,323,000 1,164,187,000 1,010,882,000 1,005,682,000 1,009,627,000 1,037,780,000 930,400,000 1,078,927,000 857,698,000 730,367,000 
      selling, general and administrative
    3,129,000,000 3,051,000,000 3,091,000,000 3,061,000,000 2,907,000,000 2,895,000,000 2,936,000,000 2,959,000,000 2,724,000,000 2,723,000,000 2,740,000,000 2,762,000,000 2,973,000,000 2,731,000,000 2,757,000,000 2,787,000,000 3,048,000,000 2,767,000,000 2,726,000,000 2,783,000,000 2,570,000,000 2,302,000,000 2,276,000,000 2,548,000,000 2,413,000,000 2,440,000,000 2,434,000,000 2,478,000,000 2,377,000,000 2,466,000,000 2,542,000,000 2,099,000,000 2,132,000,000 2,424,000,000 1,628,000,000 1,737,000,000 1,698,000,000 1,666,000,000 1,727,000,000 1,737,000,000 1,603,000,000 1,788,000,000 1,762,000,000 1,734,693,000 1,714,275,000 1,785,559,000 2,921,923,000 2,944,492,000 3,000,308,000 4,238,910,000 2,762,086,000 2,850,318,000 2,673,277,000 2,743,418,000 2,162,400,000 
      total operating cost and expenses
    9,208,000,000 9,312,000,000 9,090,000,000 8,665,000,000 9,063,000,000 8,776,000,000 8,708,000,000 8,578,000,000 8,461,000,000 8,496,000,000 8,436,000,000 8,238,000,000 8,787,000,000 8,640,000,000 8,881,000,000 8,983,000,000 9,090,000,000 8,382,000,000 8,831,000,000 8,347,000,000 8,269,000,000 7,358,000,000 6,656,000,000 6,968,000,000 6,925,000,000 6,878,000,000 6,773,000,000 6,796,000,000 6,661,000,000 6,885,000,000 6,782,000,000 6,019,000,000 6,210,000,000 6,537,000,000 4,405,000,000 4,517,000,000 4,361,000,000 4,437,000,000 4,441,000,000 4,287,000,000 4,373,000,000 4,790,000,000 4,793,000,000 4,738,799,000 4,818,549,000 4,763,107,000 7,784,188,000 7,702,679,000 7,880,911,000 9,221,787,000 7,842,838,000 7,739,701,000 7,493,320,000 7,220,048,000 6,227,871,000 
      operating earnings
    2,251,000,000 2,057,000,000 2,052,000,000 1,693,000,000 1,911,000,000 1,859,000,000 1,669,000,000 1,386,000,000 1,780,000,000 1,647,000,000 1,542,000,000 1,509,000,000 1,304,000,000 1,770,000,000 2,376,000,000 2,912,000,000 2,378,000,000 2,546,000,000 1,392,000,000 2,109,000,000 2,432,000,000 1,495,000,000 672,000,000 758,000,000 1,389,000,000 1,198,000,000 1,206,000,000 739,000,000 995,000,000 882,000,000 608,000,000 810,000,000 427,000,000  897,000,000 816,000,000 524,000,000 713,000,000 729,000,000 610,000,000 731,000,000 761,000,000 451,000,000 630,339,000 627,476,000 614,788,000 1,989,053,000 2,104,421,000 1,575,722,000 594,878,000 1,773,453,000 1,301,149,000 1,181,185,000 1,605,966,000 1,470,483,000 
      yoy
    17.79% 10.65% 22.95% 22.15% 7.36% 12.87% 8.24% -8.15% 36.50% -6.95% -35.10% -48.18% -45.16% -30.48% 70.69% 38.07% -2.22% 70.30% 107.14% 178.23% 75.09% 24.79% -44.28% 2.57% 39.60% 35.83% 98.36% -8.77% 133.02%  -32.22% -0.74% -18.51%  23.05% 33.77% -28.32% -6.31% 61.64% -3.23% 16.50% 23.78% -77.33% -70.05% -60.18% 3.35% 12.16% 61.74% 33.40% -62.96% 20.60%     
      qoq
    9.43% 0.24% 21.20% -11.41% 2.80% 11.38% 20.42% -22.13% 8.08% 6.81% 2.19% 15.72% -26.33% -25.51% -18.41% 22.46% -6.60% 82.90% -34.00% -13.28% 62.68% 122.47% -11.35% -45.43% 15.94% -0.66% 63.19% -25.73% 12.81% 45.07% -24.94% 89.70%   9.93% 55.73% -26.51% -2.19% 19.51% -16.55% -3.94% 68.74% -28.45% 0.46% 2.06% -69.09% -5.48% 33.55% 164.88% -66.46% 36.30% 10.16% -26.45% 9.21%  
      operating margin %
    19.64% 18.09% 18.42% 16.34% 17.41% 17.48% 16.08% 13.91% 17.38% 16.24% 15.45% 15.48% 12.92% 17.00% 21.11% 24.48% 20.74% 23.30% 13.62% 20.17% 22.73% 16.89% 9.17% 9.81% 16.71% 14.83% 15.11% 9.81% 13.00% 11.36% 8.23% 11.86% 6.43% 0% 16.92% 15.30% 10.73% 13.84% 14.10% 12.46% 14.32% 13.71% 8.60% 11.74% 11.52% 11.43% 20.35% 21.46% 16.66% 6.06% 18.44% 14.39% 13.62% 18.20% 19.10% 
      interest expense
    120,000,000 121,000,000 121,000,000 131,000,000 136,000,000 142,000,000 140,000,000 141,000,000 159,000,000 166,000,000 159,000,000 153,000,000 154,000,000 141,000,000 132,000,000 131,000,000 131,000,000 133,000,000 134,000,000 135,000,000 136,000,000 137,000,000 134,000,000 139,000,000 164,000,000 167,000,000 168,000,000 171,000,000 203,000,000 210,000,000 227,000,000 218,000,000 214,000,000 226,000,000 117,000,000 103,000,000 58,000,000 41,000,000 44,000,000 37,000,000 35,000,000 39,000,000 39,000,000 39,799,000 40,526,000 40,757,000 152,034,000 127,191,000 126,866,000 124,339,000 134,129,000 145,587,000 149,102,000 134,488,000 118,201,000 
      interest
    -57,500,000 -77,000,000 -71,000,000 -82,000,000 -63,250,000 -91,000,000 -82,000,000 -80,000,000 -74,000,000 -97,000,000 -98,000,000 -101,000,000 -23,750,000 -55,000,000 -26,000,000 -14,000,000 -8,000,000 -10,000,000 -11,000,000 -11,000,000 -9,250,000 -10,000,000 -9,000,000 -18,000,000 -17,250,000 -24,000,000 -22,000,000                             
      net foreign exchange loss
    -15,000,000 -17,000,000 -11,000,000 -7,000,000 -10,000,000 -11,000,000 -6,000,000  24,000,000 -10,000,000 21,000,000 6,000,000 -14,000,000 19,000,000  -3,000,000 -6,000,000 4,000,000  3,000,000 -5,000,000 -7,000,000 -1,000,000            9,000,000 10,000,000 478,000,000  5,000,000   1,000,000 2,000,000 4,599,000 10,748,000 28,865,000   24,762,000      70,019,000 
      other expense
    -134,000,000 -150,000,000 -137,000,000 -127,000,000 -154,000,000 -121,000,000 10,000,000 -111,000,000 -109,000,000 -83,000,000 -176,000,000 -111,000,000 -68,000,000 -93,000,000 -82,000,000 -78,000,000 -63,000,000 -74,000,000 -79,000,000 -61,000,000 -78,000,000 -46,000,000 22,000,000                       5,665,000  8,528,000    140,858,000 4,519,000   
      earnings before taxes
    2,358,000,000 2,180,000,000 2,150,000,000 1,778,000,000 2,030,000,000 1,940,000,000 1,607,000,000 1,436,000,000 1,795,000,000 1,671,000,000 1,636,000,000 1,562,000,000 1,746,500,000 1,758,000,000 2,352,000,000 2,876,000,000                               1,872,384,000 2,003,317,000 1,513,029,000 501,595,000 1,674,556,000 1,068,786,000 1,064,110,000 1,558,687,000 1,322,207,000 
      taxes on earnings
    582,000,000 536,000,000 371,000,000 453,000,000 -7,199,000,000 294,000,000 305,000,000 211,000,000 201,000,000 235,000,000 261,000,000 244,000,000 271,500,000 323,000,000 334,000,000 429,000,000                                278,705,000 270,905,000 198,414,000  204,968,000 173,450,000 267,037,000 319,192,000 
      net earnings
    1,776,000,000 1,644,000,000 1,779,000,000 1,325,000,000 9,229,000,000 1,646,000,000 1,302,000,000 1,225,000,000 1,594,000,000 1,436,000,000 1,375,000,000 1,318,000,000 1,033,000,000 1,435,000,000 2,018,000,000 2,447,000,000 1,989,000,000 2,100,000,000 1,189,000,000 1,793,000,000 2,162,000,000 1,232,000,000 537,000,000 564,000,000 1,049,000,000 960,000,000 1,006,000,000 672,000,000 563,000,000 733,000,000 418,000,000 603,000,000 283,000,000 419,000,000 -329,000,000 615,000,000 316,000,000 580,000,000 784,000,000 2,292,000,000 538,000,000 466,000,000 375,000,000 965,734,000 476,055,000 544,661,000 1,942,806,000 1,724,612,000 1,242,124,000 303,181,000 1,942,782,000 863,818,000 890,660,000 1,291,650,000 1,003,015,000 
      yoy
    -80.76% -0.12% 36.64% 8.16% 478.98% 14.62% -5.31% -7.06% 54.31% 0.07% -31.86% -46.14% -48.06% -31.67% 69.72% 36.48% -8.00% 70.45% 121.42% 217.91% 106.10% 28.33% -46.62% -16.07% 86.32% 30.97% 140.67% 11.44% 98.94% 74.94% -227.05% -1.95% -10.44% -27.76% -141.96% -73.17% -41.26% 24.46% 109.07% 137.33% 13.01% -14.44% -80.70% -44.00% -61.67% 79.65% 0.00% 99.65% 39.46% -76.53% 93.69%     
      qoq
    8.03% -7.59% 34.26% -85.64% 460.69% 26.42% 6.29% -23.15% 11.00% 4.44% 4.32% 27.59% -28.01% -28.89% -17.53% 23.03% -5.29% 76.62% -33.69% -17.07% 75.49% 129.42% -4.79% -46.23% 9.27% -4.57% 49.70% 19.36% -23.19% 75.36% -30.68% 113.07% -32.46% -227.36% -153.50% 94.62% -45.52% -26.02% -65.79% 326.02% 15.45% 24.27% -61.17% 102.86% -12.60% -71.97% 12.65% 38.84% 309.70% -84.39% 124.91% -3.01% -31.04% 28.78%  
      net income margin %
    15.50% 14.46% 15.97% 12.79% 84.10% 15.48% 12.55% 12.29% 15.56% 14.16% 13.78% 13.52% 10.24% 13.78% 17.93% 20.57% 17.34% 19.22% 11.63% 17.15% 20.20% 13.92% 7.33% 7.30% 12.62% 11.89% 12.61% 8.92% 7.35% 9.44% 5.66% 8.83% 4.26% 6.61% -6.21% 11.53% 6.47% 11.26% 15.16% 46.80% 10.54% 8.39% 7.15% 17.99% 8.74% 10.13% 19.88% 17.59% 13.13% 3.09% 20.20% 9.55% 10.27% 14.63% 13.03% 
      basic earnings per common share
    1,010,000 940,000 1,020,000 760,000 5,280,000 940,000 740,000 700,000 920,000 820,000 790,000 750,000 837,500 820,000 1,150,000 1,380,000                               1,220 1,090 790 190 1,240 560 580 830 650 
      diluted earnings per common share
    1,020,000 940,000 1,010,000 760,000 5,260,000 940,000 740,000 700,000 910,000 820,000 780,000 750,000 830,000 810,000 1,140,000 1,370,000                               1,210 1,080 780 190 1,230 550 570 830 640 
      average number of common shares outstanding used for basic earnings per common share
    -1,739,876,000,000 1,742,142,000,000 1,743,437,000,000 1,739,206,000,000 -1,739,129,000,000 1,739,466,000,000 1,743,040,000,000 1,740,203,000,000 -1,738,515,000,000 1,738,700,000,000 1,740,359,000,000 1,741,738,000,000 -1,754,456,000,000 1,752,968,000,000 1,753,865,000,000 1,761,911,000,000 -1,775,095,000,000 1,774,516,000,000 1,779,203,000,000 1,776,842,000,000 -1,770,393,000,000 1,774,475,000,000 1,772,953,000,000 1,768,901,000,000 -1,766,217,000,000 1,771,521,000,000 1,768,904,000,000 1,763,278,000,000 1,759,585,000,000 1,757,836,000,000 1,753,412,000,000 1,743,757,000,000 1,740,524,000,000 1,727,356,000,000 1,476,366,000,000 1,474,504,000,000 1,477,332,000,000 1,495,465,000,000 1,493,771,000,000 1,504,995,000,000 1,508,596,000,000 1,506,595,000,000 1,532,810,000,000 1,551,803,000 1,560,519,000 1,568,730,000 1,576,771,000 1,572,099,000 1,573,921,000 1,558,556,000 1,556,869,000 1,551,755,000 1,545,413,000 1,544,415,000 1,547,815,000 
      dilutive common stock options
    -7,537,000,000 7,219,000,000 7,398,000,000 8,014,000,000 -8,557,000,000 8,131,000,000 8,113,000,000 9,449,000,000 -9,810,000,000 9,589,000,000 9,889,000,000 9,977,000,000 -11,627,000,000 10,685,000,000 11,598,000,000 12,631,000,000 -14,393,000,000 14,483,000,000 14,076,000,000 14,661,000,000 -12,368,000,000 13,378,000,000 12,087,000,000 11,677,000,000 -12,805,000,000 12,646,000,000 12,513,000,000 13,295,000,000 12,095,000,000 11,114,000,000 11,866,000,000 10,399,000,000 8,359,000,000 7,839,000,000  5,988,000,000 6,341,000,000 9,702,000,000 10,444,000,000 10,542,000,000                
      average number of common shares outstanding plus dilutive common stock options
    -1,747,413,000,000 1,749,361,000,000 1,750,835,000,000 1,747,220,000,000 -1,747,686,000,000 1,747,597,000,000 1,751,153,000,000 1,749,652,000,000 -1,748,325,000,000 1,748,289,000,000 1,750,248,000,000 1,751,715,000,000 -1,766,083,000,000 1,763,653,000,000 1,765,463,000,000 1,774,542,000,000 -1,789,488,000,000 1,788,999,000,000 1,793,279,000,000 1,791,503,000,000 -1,782,761,000,000 1,787,853,000,000 1,785,040,000,000 1,780,578,000,000 -1,779,022,000,000 1,784,167,000,000 1,781,417,000,000 1,776,573,000,000 1,771,680,000,000 1,768,950,000,000 1,765,278,000,000 1,754,156,000,000 1,748,883,000,000 1,735,195,000,000 1,476,366,000,000 1,480,492,000,000 1,483,673,000,000 1,505,167,000,000 1,504,215,000,000 1,515,537,000,000                
      outstanding common stock options having no dilutive effect
    -1,430,000,000 1,443,000,000 1,442,000,000 1,431,000,000 -6,885,000,000 6,905,000,000 8,855,000,000 6,892,000,000 -5,469,000,000 7,334,000,000 5,474,000,000 7,332,000,000 -2,652,000,000 5,445,000,000 5,419,000,000 2,655,000,000 673,500,000 2,740,000,000 2,720,000,000 2,694,000,000   50,000,000 4,035,000,000  61,000,000 247,000,000 4,011,000,000 44,000,000 93,000,000  282,000,000 5,258,000,000 9,432,000,000 12,103,000,000 5,673,000,000 5,881,000,000 717,000,000 658,000,000 5,263,000,000 535,000,000 544,000,000 4,421,000,000 1,601,000 1,015,000 5,518,000 1,720,000 1,166,000 3,066,000 61,201,000 60,653,000 63,202,000 66,479,000 66,601,000 29,403,000 
      earnings from continuing operations before taxes
                    2,327,000,000 2,493,000,000 1,348,000,000  2,388,000,000 1,421,000,000 526,000,000  1,240,000,000 1,103,000,000 1,102,000,000  718,000,000 777,000,000  626,000,000 295,000,000   715,000,000  714,000,000 986,000,000 653,000,000 718,000,000 737,000,000 423,000,000 628,395,000 600,749,000 554,551,000          
      tax expense on earnings from continuing operations
                    200,500,000 393,000,000 159,000,000 250,000,000 66,750,000 189,000,000 -11,000,000        22,000,000                         
      earnings from continuing operations
                    1,989,000,000 2,100,000,000 1,189,000,000 1,793,000,000 2,158,000,000 1,232,000,000 537,000,000 544,000,000 1,049,000,000 960,000,000 1,006,000,000 672,000,000 552,000,000 718,000,000 409,000,000 561,000,000 270,000,000 386,000,000  599,000,000 56,000,000 596,000,000 786,000,000 529,000,000 440,000,000 460,000,000 339,000,000 772,863,000 476,055,000 544,661,000          
      earnings from discontinued operations, net of tax
                        5,000,000   20,000,000     11,000,000 15,000,000 9,000,000 42,000,000 13,000,000 33,000,000 28,000,000 16,000,000 244,000,000   26,000,000   36,000,000             
      basic earnings per common share —
                                                           
      continuing operations
                    1,120,000 1,180,000 670,000 1,000,000 1,210,000 690,000 300,000 310,000 590,000 540,000 570,000 380,000 310,000 410,000 230,000 320,000 150,000 220,000 -240,000 400,000 40,000 400,000 520,000 350,000 290,000 300,000 220,000 500 300 350          
      discontinued operations
                           10,000     10,000 10,000 10,000 20,000 10,000 20,000 20,000 10,000 170,000   1,170,000 70,000  20,000 120            
      diluted earnings per common share —
                                                           
      earnings from continuing operations before tax
                       2,043,000,000    633,000,000    632,000,000   431,000,000   736,000,000   2,000,000                   
      ​
                                                           
      net foreign exchange (gain) loss
                           5,000,000 -2,000,000 7,000,000 -4,000,000 6,000,000 11,000,000                           
      other income
                           -1,000,000 -51,000,000 -55,000,000 -38,000,000  18,000,000             3,000,000 3,000,000             
      tax benefit on earnings from continuing operations
                           89,000,000                                
      net income on extinguishment of debt
                                67,000,000  14,000,000                         
      taxes on earnings from continuing operations
                            191,000,000 143,000,000 96,000,000  166,000,000 59,000,000  65,000,000 25,000,000  178,000,000 116,000,000  118,000,000 200,000,000 124,000,000 278,000,000 277,000,000 84,000,000  124,694,000 9,890,000          
      cash dividends declared per common share
                                280,000 280,000 280,000 265,000 265,000 265,000 260,000 260,000 260,000 240,000 240,000 240,000 220,000 220,000 220,000 140 140 140 510 510 510 480 480 480 440 440 440 
      other expense (income)
                                   8,000,000   972,000,000 8,000,000                    
      gain on sale of discontinued operations, net of tax
                                        16,000,000 16,000,000  1,737,000,000                
      net earnings from discontinued operations, net of tax
                                   42,000,000 13,000,000 33,000,000   260,000,000   1,763,000,000                
      basic earnings (loss) per common share —
                                                           
      diluted earnings (loss) per common share —
                                                           
      other (income) expense
                                        19,000,000                   
      tax (benefit) expense on earnings from continuing operations
                                     350,000,000                      
      net earnings (loss) from discontinued operations, net of tax
                                      28,000,000 16,000,000                    
      earnings from discontinued operations, net of taxes
                                            98,000,000 6,000,000  192,871,000            
      dilutive common stock options and awards
                                            11,184,000,000 10,451,000,000 14,881,000,000 14,888,000 16,165,000 17,288,000 17,508,000 16,403,000 15,589,000 9,731,000 9,234,000 6,886,000 8,639,000 7,367,000 13,508,000 
      average number of common shares outstanding plus dilutive common stock options and awards
                                            1,519,780,000,000 1,517,046,000,000 1,547,691,000,000 1,566,691,000 1,576,684,000 1,586,018,000 1,594,279,000 1,588,502,000 1,589,510,000 1,568,287,000 1,566,103,000 1,558,641,000 1,554,052,000 1,551,782,000 1,561,323,000 
      cost of products sold
                                               2,450,532,000 2,544,825,000 2,431,803,000 3,698,078,000 3,637,305,000 3,724,921,000 3,973,250,000 3,870,472,000 3,858,983,000 3,741,116,000 3,543,932,000 3,335,104,000 
      acquired in-process and collaborations research and development
                                                   110,000,000 150,000,000       
      acquired in-process research and development
                                                      172,500,000 100,000,000  75,000,000  
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2010-09-30 2010-06-30 2010-03-31 
                                                   
        assets
                                                   
        current assets:
                                                   
        cash and cash equivalents
      7,511,000,000 6,951,000,000 6,532,000,000 7,616,000,000 7,558,000,000 6,987,000,000 6,284,000,000 6,896,000,000 6,709,000,000 7,835,000,000 9,161,000,000 9,882,000,000 9,594,000,000 8,937,000,000 7,675,000,000 9,799,000,000 9,302,000,000 8,658,000,000 8,054,000,000 6,838,000,000 4,480,000,000 4,763,000,000 3,377,000,000 3,860,000,000 4,091,000,000 3,137,000,000 3,022,000,000 7,369,000,000 3,065,000,000 3,857,000,000 11,012,000,000 9,675,000,000 8,706,000,000 2,500,000,000 2,578,000,000 3,334,000,000 3,132,000,000 4,048,000,000 3,226,000,000 3,613,000,000 3,570,000,000 2,060,000,000 3,818,145,000 4,321,702,000 1,566,820,000 
        short-term investments
      222,000,000 331,000,000 312,000,000  230,000,000 232,000,000 367,000,000  338,000,000 320,000,000 371,000,000  313,000,000 353,000,000 483,000,000  390,000,000 286,000,000 318,000,000  251,000,000 274,000,000 291,000,000  244,000,000 239,000,000 239,000,000 181,000,000 199,000,000 185,000,000 187,000,000 160,000,000 154,000,000 2,007,000,000 1,860,000,000 623,000,000 3,007,000,000 7,129,000,000 6,623,000,000       
        trade receivables, less allowances of 490 in 2025 and 439 in 2024
      8,138,000,000                                             
        inventories:
                                                   
        finished products
      4,130,000,000 4,319,000,000 4,063,000,000 3,700,000,000 4,173,000,000 4,060,000,000 4,063,000,000 3,946,000,000 3,847,000,000 4,004,000,000 3,944,000,000 3,805,000,000 3,407,000,000 3,570,000,000 3,470,000,000 3,081,000,000 3,048,000,000 3,118,000,000 3,219,000,000 3,030,000,000 3,173,000,000 3,240,000,000 2,873,000,000 2,784,000,000 2,846,000,000 2,786,000,000 2,641,000,000 2,340,000,000 2,264,000,000 2,424,000,000 2,273,000,000 2,355,000,000 2,704,000,000 1,763,000,000 1,865,000,000 1,980,000,000 1,810,000,000 1,869,000,000 1,780,000,000 1,873,000,000 1,920,000,000 1,921,000,000 2,025,154,000 1,933,692,000 2,138,884,000 
        work in process
      961,000,000 962,000,000 890,000,000 840,000,000 877,000,000 880,000,000 881,000,000 807,000,000 888,000,000 845,000,000 805,000,000 680,000,000 726,000,000 710,000,000 695,000,000 694,000,000 710,000,000 796,000,000 773,000,000 712,000,000 721,000,000 675,000,000 615,000,000 560,000,000 584,000,000 584,000,000 536,000,000 561,000,000 563,000,000 536,000,000 456,000,000 450,000,000 509,000,000 326,000,000 340,000,000 306,000,000 289,000,000 303,000,000 287,000,000 290,000,000 339,000,000 322,000,000 705,676,000 724,835,000 746,890,000 
        materials
      1,617,000,000 1,673,000,000 1,686,000,000 1,654,000,000 1,763,000,000 1,874,000,000 1,883,000,000 1,817,000,000 1,915,000,000 2,022,000,000 1,924,000,000 1,688,000,000 1,601,000,000 1,619,000,000 1,526,000,000 1,382,000,000 1,503,000,000 1,525,000,000 1,395,000,000 1,270,000,000 1,258,000,000 1,287,000,000 1,080,000,000 972,000,000 962,000,000 982,000,000 908,000,000 880,000,000 887,000,000 866,000,000 754,000,000 798,000,000 782,000,000 524,000,000 608,000,000 500,000,000 534,000,000 563,000,000 556,000,000 533,000,000 564,000,000 532,000,000 577,928,000 510,114,000 525,147,000 
        total inventories
      6,708,000,000 6,954,000,000 6,639,000,000 6,194,000,000 6,813,000,000 6,814,000,000 6,827,000,000 6,570,000,000 6,650,000,000 6,871,000,000 6,673,000,000 6,173,000,000 5,734,000,000 5,899,000,000 5,691,000,000 5,157,000,000 5,261,000,000 5,439,000,000 5,387,000,000 5,012,000,000 5,152,000,000 5,202,000,000 4,568,000,000 4,316,000,000 4,392,000,000 4,352,000,000 4,085,000,000 3,781,000,000 3,714,000,000 3,826,000,000 3,483,000,000 3,603,000,000 3,995,000,000 2,613,000,000 2,813,000,000 2,786,000,000 2,633,000,000 2,735,000,000 2,623,000,000 2,696,000,000 2,823,000,000 2,775,000,000 3,308,758,000 3,168,641,000 3,410,921,000 
        prepaid expenses and other receivables
      2,260,000,000 2,260,000,000 2,343,000,000  2,150,000,000 2,232,000,000 2,293,000,000  2,468,000,000 2,307,000,000 2,152,000,000  2,796,000,000 2,568,000,000 2,401,000,000  2,134,000,000 2,131,000,000 1,962,000,000  1,858,000,000 1,842,000,000 1,970,000,000  1,942,000,000 1,919,000,000 1,718,000,000 1,582,000,000 1,935,000,000 1,720,000,000 1,895,000,000 1,912,000,000 1,964,000,000 1,986,000,000 2,104,000,000 2,157,000,000          
        total current assets
      24,839,000,000 24,468,000,000 23,153,000,000 23,656,000,000 23,802,000,000 23,119,000,000 22,376,000,000 22,670,000,000 22,664,000,000 23,505,000,000 24,377,000,000 25,224,000,000 24,845,000,000 24,956,000,000 23,429,000,000 24,239,000,000 23,492,000,000 22,627,000,000 21,817,000,000 20,441,000,000 17,390,000,000 17,221,000,000 15,498,000,000 15,667,000,000 16,119,000,000 15,195,000,000 14,409,000,000 18,196,000,000 14,122,000,000 14,964,000,000 21,377,000,000 19,983,000,000 19,329,000,000 12,978,000,000 12,988,000,000 12,406,000,000 15,894,000,000 21,131,000,000 19,985,000,000 16,464,000,000 18,258,000,000 17,931,000,000 19,447,420,000 19,915,307,000 17,690,678,000 
        investments
      951,000,000 958,000,000 907,000,000 886,000,000 912,000,000 877,000,000 818,000,000 799,000,000 788,000,000 799,000,000 776,000,000 766,000,000 764,000,000 734,000,000 763,000,000 816,000,000 812,000,000 805,000,000 832,000,000 821,000,000 803,000,000 776,000,000 790,000,000 883,000,000 874,000,000 851,000,000 867,000,000 971,000,000 940,000,000 913,000,000 1,386,000,000 1,545,000,000 1,756,000,000 2,997,000,000 3,339,000,000 3,552,000,000 3,055,000,000 243,000,000 244,000,000 221,000,000 130,000,000 122,000,000 255,153,000 251,240,000 1,120,483,000 
        property and equipment, at cost
      24,816,000,000 24,472,000,000 23,418,000,000  22,857,000,000 22,061,000,000 22,055,000,000  21,111,000,000 20,926,000,000 20,605,000,000  19,306,000,000 19,458,000,000 19,521,000,000  19,182,000,000 19,074,000,000 18,697,000,000  17,972,000,000 17,374,000,000 16,707,000,000  16,343,000,000 16,331,000,000 15,905,000,000 15,520,000,000 15,309,000,000 15,556,000,000 14,698,000,000 14,476,000,000 14,172,000,000 12,452,000,000 12,712,000,000 12,709,000,000 12,528,000,000 12,433,000,000 12,251,000,000 12,694,000,000 13,096,000,000 13,005,000,000 17,259,216,000 16,856,968,000 16,803,187,000 
        less: accumulated depreciation and amortization
      13,312,000,000 13,077,000,000 12,486,000,000 12,082,000,000 12,236,000,000 11,828,000,000 11,948,000,000 11,779,000,000 11,559,000,000 11,477,000,000 11,323,000,000 11,050,000,000 10,617,000,000 10,640,000,000 10,613,000,000 10,405,000,000 10,351,000,000 10,258,000,000 9,865,000,000 9,764,000,000 9,352,000,000 9,031,000,000 8,800,000,000 8,761,000,000 8,518,000,000 8,506,000,000 8,279,000,000 8,072,000,000 7,877,000,000 7,897,000,000 7,479,000,000 7,190,000,000 6,907,000,000 6,718,000,000 6,886,000,000 6,873,000,000 6,731,000,000 6,695,000,000 6,552,000,000 6,822,000,000 7,161,000,000 7,057,000,000 9,319,429,000 8,981,360,000 8,743,073,000 
        net property and equipment
      11,504,000,000 11,395,000,000 10,932,000,000 10,658,000,000 10,621,000,000 10,233,000,000 10,107,000,000 10,154,000,000 9,552,000,000 9,449,000,000 9,282,000,000 9,162,000,000 8,689,000,000 8,818,000,000 8,908,000,000 8,959,000,000 8,831,000,000 8,816,000,000 8,832,000,000 9,029,000,000 8,620,000,000 8,343,000,000 7,907,000,000 8,038,000,000 7,825,000,000 7,825,000,000 7,626,000,000 7,448,000,000 7,432,000,000 7,659,000,000 7,219,000,000 7,286,000,000 7,265,000,000 5,734,000,000 5,826,000,000 5,836,000,000 5,797,000,000 5,738,000,000 5,699,000,000 5,872,000,000 5,935,000,000 5,948,000,000 7,939,787,000 7,875,608,000 8,060,114,000 
        intangible assets, net of amortization
      5,598,000,000 5,920,000,000 6,261,000,000 6,647,000,000 7,352,000,000 7,827,000,000 8,296,000,000 8,815,000,000 9,282,000,000 9,834,000,000 10,006,000,000 10,454,000,000 10,850,000,000 11,592,000,000 12,225,000,000 12,739,000,000 13,312,000,000 13,681,000,000 14,181,000,000 14,784,000,000 15,208,000,000 15,783,000,000 16,265,000,000 17,025,000,000 17,465,000,000 18,091,000,000 18,472,000,000 19,477,000,000 19,951,000,000 20,943,000,000 18,578,000,000 18,653,000,000 19,405,000,000 4,674,000,000 5,311,000,000 5,458,000,000 5,844,000,000 5,785,000,000 5,979,000,000 6,094,000,000 5,428,000,000 5,613,000,000 12,646,677,000 10,266,399,000 10,663,369,000 
        goodwill
      23,971,000,000 23,952,000,000 23,359,000,000 23,108,000,000 23,658,000,000 23,308,000,000 23,383,000,000 23,679,000,000 23,277,000,000 23,258,000,000 22,927,000,000 22,799,000,000 22,284,000,000 22,744,000,000 23,179,000,000 23,231,000,000 23,299,000,000 23,485,000,000 23,384,000,000 23,744,000,000 23,338,000,000 23,082,000,000 22,927,000,000 23,195,000,000 23,046,000,000 23,329,000,000 23,209,000,000 23,416,000,000 23,844,000,000 24,227,000,000 22,066,000,000 22,132,000,000 21,353,000,000 7,812,000,000 9,752,000,000 9,775,000,000 9,750,000,000 9,896,000,000 9,855,000,000 10,048,000,000 9,751,000,000 9,781,000,000 15,807,536,000 14,218,098,000 15,007,686,000 
        deferred income taxes and other assets
      17,318,000,000 17,306,000,000 16,836,000,000 16,459,000,000 8,011,000,000 7,653,000,000 7,487,000,000 7,097,000,000 6,527,000,000 6,509,000,000 6,426,000,000 6,033,000,000 5,369,000,000 5,358,000,000 5,503,000,000 5,212,000,000 4,049,000,000 3,855,000,000 3,739,000,000 3,729,000,000 3,684,000,000 3,571,000,000 3,390,000,000 3,079,000,000 3,210,000,000 3,136,000,000 3,027,000,000 2,110,000,000 2,005,000,000 2,082,000,000 1,565,000,000 1,552,000,000 1,779,000,000 2,523,000,000 2,613,000,000 2,608,000,000 1,383,000,000 1,330,000,000 1,330,000,000 1,772,000,000 1,921,000,000 2,214,000,000 1,277,047,000 854,750,000 816,292,000 
        liabilities and shareholders’ investment
                                                   
        current liabilities:
                                                   
        trade accounts payable
      4,123,000,000 4,306,000,000 4,214,000,000 4,195,000,000 4,034,000,000 4,125,000,000 4,178,000,000 4,295,000,000 3,961,000,000 4,211,000,000 4,167,000,000 4,607,000,000 4,133,000,000 4,493,000,000 4,757,000,000 4,408,000,000 4,017,000,000 4,017,000,000 4,066,000,000 3,946,000,000 3,189,000,000 3,335,000,000 3,181,000,000 3,252,000,000 3,029,000,000 3,222,000,000 3,045,000,000 2,730,000,000 2,503,000,000 2,476,000,000 1,858,000,000 1,667,000,000 1,481,000,000 1,051,000,000 1,153,000,000 1,053,000,000 1,007,000,000 1,000,000,000 1,012,000,000 965,000,000 1,062,000,000 1,074,000,000 1,531,720,000 1,615,606,000 1,663,523,000 
        salaries, wages and commissions
      1,735,000,000 1,550,000,000 1,167,000,000 1,701,000,000 1,618,000,000 1,389,000,000 1,092,000,000 1,597,000,000 1,479,000,000 1,362,000,000 1,098,000,000 1,556,000,000 1,426,000,000 1,315,000,000 1,147,000,000 1,625,000,000 1,470,000,000 1,248,000,000 1,117,000,000 1,416,000,000 1,439,000,000 1,121,000,000 949,000,000 1,237,000,000 1,258,000,000 1,018,000,000 886,000,000 1,241,000,000 1,034,000,000 949,000,000 1,103,000,000 905,000,000 802,000,000 799,000,000 717,000,000 606,000,000 854,000,000 759,000,000 649,000,000 867,000,000 828,000,000 681,000,000    
        other accrued liabilities
      5,880,000,000 5,656,000,000 5,600,000,000 5,143,000,000 5,427,000,000 5,071,000,000 5,220,000,000 5,422,000,000 5,347,000,000 5,334,000,000 5,758,000,000 5,845,000,000 5,475,000,000 5,400,000,000 5,577,000,000 5,181,000,000 5,264,000,000 5,354,000,000 5,247,000,000 5,165,000,000 4,659,000,000 4,206,000,000 4,408,000,000 4,035,000,000 4,112,000,000 3,961,000,000 4,130,000,000 3,807,000,000 3,887,000,000 4,144,000,000 3,617,000,000 3,357,000,000 3,506,000,000 2,715,000,000 2,931,000,000 3,118,000,000 3,294,000,000 3,288,000,000 3,380,000,000 2,875,000,000 3,247,000,000 3,401,000,000 5,677,368,000   
        dividends payable
      1,030,000,000 1,030,000,000 1,032,000,000 1,024,000,000 956,000,000 959,000,000 959,000,000 955,000,000 886,000,000 886,000,000 888,000,000 887,000,000 820,000,000 824,000,000 824,000,000 831,000,000 797,000,000 799,000,000 801,000,000 798,000,000 639,000,000 637,000,000 637,000,000 635,000,000 567,000,000 566,000,000 566,000,000 493,000,000 492,000,000 492,000,000 462,000,000 461,000,000 461,000,000 384,000,000 383,000,000 382,000,000 359,000,000 358,000,000 358,000,000 332,000,000 331,000,000 331,000,000    
        income taxes payable
      469,000,000 390,000,000 485,000,000 594,000,000 713,000,000 601,000,000 562,000,000 492,000,000 318,000,000 273,000,000 334,000,000 343,000,000 394,000,000 355,000,000 338,000,000 306,000,000 368,000,000 242,000,000 276,000,000 362,000,000 117,000,000 165,000,000 165,000,000 226,000,000 67,000,000 83,000,000 277,000,000 231,000,000 188,000,000 212,000,000 180,000,000 192,000,000 186,000,000 240,000,000 232,000,000 261,000,000 483,000,000 589,000,000 534,000,000 481,000,000 181,000,000 152,000,000 874,915,000 906,674,000 769,488,000 
        current portion of long-term debt
      1,345,000,000 507,000,000 506,000,000 1,500,000,000 2,154,000,000 1,615,000,000 2,010,000,000 1,080,000,000 1,051,000,000 2,284,000,000 2,285,000,000 2,251,000,000 1,117,000,000 5,000,000 4,000,000 754,000,000 754,000,000 755,000,000 756,000,000 7,000,000 6,000,000 1,290,000,000 1,264,000,000 1,277,000,000 1,254,000,000 8,000,000 8,000,000 4,063,000,000 506,000,000 507,000,000 504,000,000 3,000,000 3,000,000 4,000,000 4,000,000 3,000,000 32,000,000 32,000,000 51,000,000 206,000,000 9,000,000 8,000,000 2,218,542,000 2,217,419,000 718,093,000 
        total current liabilities
      14,582,000,000 13,439,000,000 13,004,000,000 14,157,000,000 14,902,000,000 13,760,000,000 14,021,000,000 13,841,000,000 13,042,000,000 14,350,000,000 14,530,000,000 15,489,000,000 13,365,000,000 12,392,000,000 12,647,000,000 13,105,000,000 12,867,000,000 12,614,000,000 12,462,000,000 11,907,000,000 10,257,000,000 10,959,000,000 10,808,000,000 10,863,000,000 10,491,000,000 9,062,000,000 9,113,000,000 12,776,000,000 8,951,000,000 9,010,000,000 7,935,000,000 6,803,000,000 6,646,000,000 8,321,000,000 8,673,000,000 8,393,000,000 8,755,000,000 9,185,000,000 9,206,000,000 10,823,000,000 9,853,000,000 10,186,000,000 15,583,871,000 14,689,260,000 15,183,485,000 
        long-term debt
      11,596,000,000 12,930,000,000 12,736,000,000 12,625,000,000 12,825,000,000 13,139,000,000 12,576,000,000 13,599,000,000 14,477,000,000 14,562,000,000 14,615,000,000 14,522,000,000 15,297,000,000 16,755,000,000 17,086,000,000 17,296,000,000 17,446,000,000 17,547,000,000 17,489,000,000 18,527,000,000 18,349,000,000 18,184,000,000 16,804,000,000 16,661,000,000 17,639,000,000 18,982,000,000 18,845,000,000 19,284,000,000 19,823,000,000 21,154,000,000 23,310,000,000 23,810,000,000 23,764,000,000 5,975,000,000 6,016,000,000 5,977,000,000 5,953,000,000 5,862,000,000 5,931,000,000 3,719,000,000 3,403,000,000 3,387,000,000 12,910,681,000 12,612,655,000 10,878,649,000 
        post-employment obligations, deferred income taxes and other long-term liabilities
      6,739,000,000 6,801,000,000 6,644,000,000  6,601,000,000 6,558,000,000 6,827,000,000  6,877,000,000 7,038,000,000 7,417,000,000  8,255,000,000 8,339,000,000 8,645,000,000  8,844,000,000 9,079,000,000 9,046,000,000  8,842,000,000 8,835,000,000 8,738,000,000  8,390,000,000 8,489,000,000 8,523,000,000 8,679,000,000 8,867,000,000 9,143,000,000 8,785,000,000 8,750,000,000 8,930,000,000 4,245,000,000 4,347,000,000 4,425,000,000 5,798,000,000 5,952,000,000 5,970,000,000 4,883,000,000 4,514,000,000 4,599,000,000   6,284,148,000 
        commitments and contingencies
                                                   
        shareholders’ investment:
                                                   
        preferred shares, one dollar par value authorized — 1,000,000 shares, none issued
                                                   
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2025: 1,996,743,794; 2024: 1,991,472,630
      25,412,000,000                                             
        common shares held in treasury, at cost — shares: 2025: 257,871,122; 2024: 259,774,639
      -16,877,000,000                                             
        earnings employed in the business
      49,103,000,000 48,467,000,000 47,715,000,000 47,261,000,000 39,056,000,000 38,354,000,000 38,011,000,000 37,554,000,000 36,920,000,000 36,355,000,000 35,868,000,000 35,257,000,000 35,115,000,000 34,487,000,000 33,295,000,000 31,528,000,000 30,376,000,000 29,053,000,000 28,669,000,000 27,627,000,000 26,266,000,000 25,669,000,000 25,786,000,000 25,847,000,000 25,440,000,000 25,045,000,000 24,613,000,000 24,144,000,000 24,080,000,000 23,856,000,000 25,320,000,000 25,202,000,000 25,387,000,000 25,162,000,000 25,884,000,000 25,654,000,000 25,375,000,000 25,162,000,000 24,740,000,000 22,335,000,000 22,137,000,000 22,005,000,000 18,181,133,000 17,978,462,000 17,367,857,000 
        accumulated other comprehensive income
      -6,684,000,000 -6,576,000,000 -7,417,000,000 -7,906,000,000 -7,804,000,000 -8,135,000,000 -8,166,000,000 -7,839,000,000 -8,480,000,000 -8,071,000,000 -8,039,000,000 -8,051,000,000 -9,445,000,000 -8,706,000,000 -8,474,000,000 -8,374,000,000 -9,240,000,000 -9,066,000,000 -9,285,000,000 -8,946,000,000 -9,044,000,000 -9,080,000,000 -9,386,000,000 -8,465,000,000 -7,763,000,000 -7,365,000,000                    
        total abbott shareholders’ investment
      50,954,000,000 50,565,000,000 48,811,000,000 47,664,000,000 39,796,000,000 39,318,000,000 38,810,000,000 38,603,000,000 37,481,000,000 37,174,000,000 37,010,000,000 36,686,000,000 35,675,000,000 36,490,000,000 35,399,000,000 35,802,000,000 34,422,000,000 33,800,000,000 33,562,000,000 32,784,000,000 31,386,000,000 30,578,000,000 30,218,000,000 31,088,000,000 31,817,000,000 31,686,000,000 30,925,000,000 30,705,000,000 30,577,000,000 31,399,000,000 32,032,000,000 31,602,000,000 31,362,000,000 20,776,000,000 20,675,000,000 20,722,000,000 21,111,000,000 23,008,000,000 21,874,000,000 22,888,000,000 23,602,000,000 23,390,000,000 21,403,932,000 19,911,709,000 20,860,099,000 
        noncontrolling interests
      310,000,000                                             
        total shareholders’ investment
      51,264,000,000 50,829,000,000 49,064,000,000 47,901,000,000 40,028,000,000 39,560,000,000 39,043,000,000 38,827,000,000 37,694,000,000 37,404,000,000 37,232,000,000 36,905,000,000 35,884,000,000 36,716,000,000 35,629,000,000 36,024,000,000 34,638,000,000 34,029,000,000 33,788,000,000 33,003,000,000 31,595,000,000 30,798,000,000 30,427,000,000 31,301,000,000 32,019,000,000 31,894,000,000 31,129,000,000 30,898,000,000 30,774,000,000 31,601,000,000 32,218,000,000 31,788,000,000 31,547,000,000 20,896,000,000 20,795,000,000 20,842,000,000 21,219,000,000 23,126,000,000 21,988,000,000 22,993,000,000 23,704,000,000 23,489,000,000    
        common shares:
                                                   
        balance at june 30
      48,467,000,000 48,467,000,000   38,354,000,000 38,354,000,000   36,355,000,000 36,355,000,000   34,487,000,000 34,487,000,000        25,669,000,000   25,045,000,000 25,045,000,000                    
        shares: 2025: 1,996,448,469; 2024: 1,990,029,292
      25,284,000,000 25,284,000,000                                            
        issued under incentive stock programs
                                                   
        shares: 2025: 295,325; 2024: 1,022,122
      15,000,000                                             
        share-based compensation
      120,000,000 128,000,000 303,000,000  117,000,000 124,000,000 322,000,000  116,000,000 119,000,000 296,000,000  123,000,000 125,000,000        105,000,000 245,000,000  93,000,000 106,000,000 237,000,000 396,000,000 313,000,000 212,000,000 338,000,000 263,000,000 171,000,000 263,000,000 214,000,000 152,000,000 249,000,000 205,000,000 148,000,000 208,000,000 168,000,000 119,000,000    
        issuance of restricted stock awards
      -7,000,000 -5,000,000 -570,000,000  -3,000,000 -5,000,000 -552,000,000  -7,000,000 -9,000,000 -533,000,000  -4,000,000 -10,000,000        -9,000,000 -420,000,000  -5,000,000 -13,000,000                    
        balance at september 30
      49,103,000,000    39,056,000,000    36,920,000,000    35,115,000,000            25,440,000,000                     
        shares: 2025: 1,996,743,794; 2024: 1,991,051,414
      25,412,000,000                                             
        common shares held in treasury:
                                                   
        shares: 2025: 255,988,730; 2024: 250,131,563
      -16,610,000,000 -16,610,000,000                                            
        shares: 2025: 543,100; 2024: 545,287
      36,000,000                                             
        purchased
                                                   
        shares: 2025: 2,425,492; 2024: 7,009,200
      -303,000,000                                             
        shares: 2025: 257,871,122; 2024: 256,595,476
      -16,877,000,000                                             
        earnings employed in the business:
                                                   
        net earnings
      1,644,000,000 1,779,000,000 1,325,000,000  1,646,000,000 1,302,000,000 1,225,000,000  1,436,000,000 1,375,000,000 1,318,000,000  1,435,000,000 2,018,000,000        537,000,000 564,000,000  960,000,000 1,006,000,000 672,000,000 1,714,000,000 1,151,000,000 418,000,000 1,305,000,000 702,000,000 419,000,000 602,000,000 931,000,000 316,000,000 3,656,000,000 3,076,000,000 2,292,000,000 1,380,000,000 841,000,000 375,000,000    
        cash dividends declared on common shares
      -1,030,000,000 -1,028,000,000 -1,033,000,000  -958,000,000 -961,000,000 -960,000,000  -889,000,000 -889,000,000 -890,000,000  -822,000,000 -827,000,000        -640,000,000 -641,000,000  -570,000,000 -568,000,000                    
        effect of common and treasury share transactions
      22,000,000 1,000,000 162,000,000  14,000,000 2,000,000 192,000,000  18,000,000 1,000,000 183,000,000  15,000,000 1,000,000        -14,000,000 21,000,000  5,000,000 -6,000,000                    
        accumulated other comprehensive income:
                                                   
        other comprehensive income
      -108,000,000 841,000,000 489,000,000  331,000,000 31,000,000 -327,000,000  -409,000,000 -32,000,000 12,000,000  -739,000,000 -232,000,000        306,000,000 -921,000,000  -398,000,000 105,000,000 116,000,000                   
        noncontrolling interests in subsidiaries:
                                                   
        noncontrolling interests’ share of income, net of distributions and share repurchases
      46,000,000                                             
        trade receivables, less allowances of 471 in 2025 and 439 in 2024
       7,972,000,000                                            
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2025: 1,996,448,469; 2024: 1,991,472,630
       25,284,000,000                                            
        common shares held in treasury, at cost — shares: 2025: 255,988,730; 2024: 259,774,639
       -16,610,000,000                                            
        noncontrolling interests in subsidiaries
       264,000,000 253,000,000 237,000,000 232,000,000 242,000,000 233,000,000 224,000,000 213,000,000 230,000,000 222,000,000 219,000,000 209,000,000 226,000,000 230,000,000 222,000,000 216,000,000 229,000,000 226,000,000 219,000,000 209,000,000 220,000,000 209,000,000 213,000,000 202,000,000 208,000,000 204,000,000 193,000,000 197,000,000 202,000,000 186,000,000 186,000,000 185,000,000 120,000,000 120,000,000 120,000,000 108,000,000 118,000,000 114,000,000 105,000,000 102,000,000 99,000,000 78,792,000 82,925,000 152,241,000 
        balance at march 31
       47,715,000,000 47,715,000,000   38,011,000,000 38,011,000,000   35,868,000,000 35,868,000,000   33,295,000,000        25,786,000,000 25,786,000,000   24,613,000,000 24,613,000,000                   
        shares: 2025: 1,995,858,606; 2024: 1,989,789,999
       25,125,000,000 25,125,000,000                                           
        shares: 2025: 589,863; 2024: 239,293
       36,000,000                                            
        shares: 2025: 256,021,416; 2024: 250,155,515
       -16,612,000,000 -16,612,000,000                                           
        shares: 2025: 34,961; 2024: 27,310
       3,000,000                                            
        shares: 2025: 2,275; 2024: 3,358
       -1,000,000                                            
        noncontrolling interests’ share of income, business combinations, net of distributions and share repurchases
       11,000,000 16,000,000  -10,000,000 9,000,000 9,000,000  -17,000,000 8,000,000 3,000,000  -17,000,000 -4,000,000        11,000,000 -4,000,000  -6,000,000 4,000,000 6,000,000                   
        trade receivables, less allowances of 449 in 2025 and 439 in 2024
        7,327,000,000                                           
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2025: 1,995,858,606; 2024: 1,991,472,630
        25,125,000,000                                           
        common shares held in treasury, at cost — shares: 2025: 256,021,416; 2024: 259,774,639
        -16,612,000,000                                           
        balance at january 1
        47,261,000,000    37,554,000,000    35,257,000,000            25,847,000,000    24,560,000,000                   
        shares: 2025: 1,991,472,630; 2024: 1,987,883,852
        25,153,000,000                                           
        shares: 2025: 4,385,976; 2024: 1,906,147
        239,000,000                                           
        shares: 2025: 259,774,639; 2024: 253,807,494
        -16,844,000,000                                           
        shares: 2025: 3,935,939; 2024: 3,838,255
        256,000,000                                           
        shares: 2025: 182,716; 2024: 186,276
        -24,000,000                                           
        investments, primarily bank time deposits and u.s. treasury bills
         351,000,000    383,000,000    288,000,000    450,000,000    310,000,000    280,000,000                1,264,000,000 3,492,000,000 4,987,000,000    
        trade receivables, less allowances of — 2024: 439; 2023: 444
         6,925,000,000                                          
        other prepaid expenses and receivables
         2,570,000,000    2,256,000,000    2,663,000,000    2,346,000,000    1,867,000,000    1,786,000,000                      
        property and equipment, at cost:
                                                   
        land
         528,000,000    529,000,000    511,000,000    525,000,000    538,000,000    519,000,000                      
        buildings
         4,207,000,000    4,161,000,000    4,053,000,000    4,007,000,000    4,014,000,000    3,702,000,000                      
        equipment
         15,517,000,000    15,179,000,000    14,164,000,000    13,528,000,000    12,884,000,000    11,468,000,000                      
        construction in progress
         2,488,000,000    2,064,000,000    1,484,000,000    1,304,000,000    1,357,000,000    1,110,000,000                      
        post-employment obligations and other long-term liabilities
         6,731,000,000    6,947,000,000    7,522,000,000    8,771,000,000    9,111,000,000    9,062,000,000                   7,396,344,000 6,084,853,000  
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,991,472,630; 2023: 1,987,883,852
         25,153,000,000                                          
        common shares held in treasury, at cost — shares: 2024: 259,774,639; 2023: 253,807,494
         -16,844,000,000                                          
        trade receivables, less allowances of 456 in 2024 and 444 in 2023
          7,051,000,000                                         
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,991,051,414; 2023: 1,987,883,852
          25,020,000,000                                         
        common shares held in treasury, at cost — shares: 2024: 256,595,476; 2023: 253,807,494
          -16,476,000,000                                         
        shares: 2024: 1,990,029,292; 2023: 1,987,181,491
          24,858,000,000 24,858,000,000                                        
        shares: 2024: 1,022,122; 2023: 123,663
          48,000,000                                         
        shares: 2024: 1,991,051,414; 2023: 1,987,305,154
          25,020,000,000                                         
        shares: 2024: 250,131,563; 2023: 251,823,511
          -15,759,000,000 -15,759,000,000                                        
        shares: 2024: 545,287; 2023: 579,159
          35,000,000                                         
        shares: 2024: 7,009,200; 2023: 2,266
          -752,000,000                                         
        shares: 2024: 256,595,476; 2023: 251,246,618
          -16,476,000,000                                         
        trade receivables, less allowances of 441 in 2024 and 444 in 2023
           6,854,000,000                                        
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,990,029,292; 2023: 1,987,883,852
           24,858,000,000                                        
        common shares held in treasury, at cost — shares: 2024: 250,131,563; 2023: 253,807,494
           -15,759,000,000                                        
        shares: 2024: 1,989,789,999; 2023: 1,986,904,170
           24,726,000,000 24,726,000,000                                       
        shares: 2024: 239,293; 2023: 277,321
           13,000,000                                        
        shares: 2024: 250,155,515; 2023: 247,957,371
           -15,761,000,000 -15,761,000,000                                       
        shares: 2024: 27,310; 2023: 157,305
           2,000,000                                        
        shares: 2024: 3,358; 2023: 4,023,445
                                                   
        trade receivables, less allowances of 439 in 2024 and 444 in 2023
            6,605,000,000                                       
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2024: 1,989,789,999; 2023: 1,987,883,852
            24,726,000,000                                       
        common shares held in treasury, at cost — shares: 2024: 250,155,515; 2023: 253,807,494
            -15,761,000,000                                       
        shares: 2024: 1,987,883,852; 2023: 1,986,519,278
            24,869,000,000                                       
        shares: 2024: 1,906,147; 2023: 384,892
            87,000,000                                       
        shares: 2024: 253,807,494; 2023: 248,724,257
            -15,981,000,000                                       
        shares: 2024: 3,838,255; 2023: 3,933,165
            242,000,000                                       
        shares: 2024: 186,276; 2023: 3,166,279
            -22,000,000                                       
        trade receivables, less allowances of — 2023: 444; 2022: 500
             6,565,000,000                                      
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,987,883,852; 2022: 1,986,519,278
             24,869,000,000                                      
        common shares held in treasury, at cost — shares: 2023: 253,807,494; 2022: 248,724,257
             -15,981,000,000                                      
        trade receivables, less allowances of 472 in 2023 and 500 in 2022
              6,499,000,000                                     
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,987,305,154; 2022: 1,986,519,278
              24,727,000,000                                     
        common shares held in treasury, at cost — shares: 2023: 251,246,618; 2022: 248,724,257
              -15,686,000,000                                     
        shares: 2023: 1,987,181,491; 2022: 1,985,676,735
              24,612,000,000 24,612,000,000                                    
        shares: 2023: 123,663; 2022: 242,705
              6,000,000                                     
        shares: 2023: 1,987,305,154; 2022: 1,985,919,440
              24,727,000,000                                     
        shares: 2023: 251,823,511; 2022: 234,456,992
              -15,722,000,000 -15,722,000,000                                    
        shares: 2023: 579,159; 2022: 528,436
              36,000,000                                     
        shares: 2023: 2,266; 2022: 8,417,107
                                                   
        shares: 2023: 251,246,618; 2022: 242,345,663
              -15,686,000,000                                     
        trade receivables, less allowances of 485 in 2023 and 500 in 2022
               6,172,000,000                                    
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,987,181,491; 2022: 1,986,519,278
               24,612,000,000                                    
        common shares held in treasury, at cost — shares: 2023: 251,823,511; 2022: 248,724,257
               -15,722,000,000                                    
        shares: 2023: 1,986,904,170; 2022: 1,985,525,053
               24,488,000,000 24,488,000,000                                   
        shares: 2023: 277,321; 2022: 151,682
               14,000,000                                    
        shares: 2023: 247,957,371; 2022: 234,582,764
               -15,307,000,000 -15,307,000,000                                   
        shares: 2023: 157,305; 2022: 135,663
               10,000,000                                    
        shares: 2023: 4,023,445; 2022: 9,891
               -425,000,000                                    
        trade receivables, less allowances of 503 in 2023 and 500 in 2022
                6,020,000,000                                   
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2023: 1,986,904,170; 2022: 1,986,519,278
                24,488,000,000                                   
        common shares held in treasury, at cost — shares: 2023: 247,957,371; 2022: 248,724,257
                -15,307,000,000                                   
        shares: 2023: 1,986,519,278; 2022: 1,985,273,421
                24,709,000,000                                   
        shares: 2023: 384,892; 2022: 251,632
                16,000,000                                   
        shares: 2023: 248,724,257; 2022: 221,191,228
                -15,229,000,000                                   
        shares: 2023: 3,933,165; 2022: 4,144,476
                242,000,000                                   
        shares: 2023: 3,166,279; 2022: 17,536,012
                -320,000,000                                   
        trade receivables, less allowances of — 2022: 500; 2021: 519
                 6,218,000,000                                  
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,986,519,278; 2021: 1,985,273,421
                 24,709,000,000                                  
        common shares held in treasury, at cost — shares: 2022: 248,724,257; 2021: 221,191,228
                 -15,229,000,000                                  
        trade receivables, less allowances of 520 in 2022 and 519 in 2021
                  6,408,000,000                                 
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,985,919,440; 2021: 1,985,273,421
                  24,560,000,000                                 
        common shares held in treasury, at cost — shares: 2022: 242,345,663; 2021: 221,191,228
                  -14,555,000,000                                 
        shares: 2022: 1,985,676,735; 2021: 1,982,553,488
                  24,429,000,000 24,429,000,000                                
        shares: 2022: 242,705; 2021: 550,366
                  12,000,000                                 
        shares: 2022: 1,985,919,440; 2021: 1,983,103,854
                  24,560,000,000                                 
        shares: 2022: 234,456,992; 2021: 209,736,139
                  -13,720,000,000 -13,720,000,000                                
        shares: 2022: 528,436; 2021: 545,860
                  31,000,000                                 
        shares: 2022: 8,417,107; 2021: 5,626,606
                  -866,000,000                                 
        shares: 2022: 242,345,663; 2021: 214,816,885
                  -14,555,000,000                                 
        trade receivables, less allowances of 572 in 2022 and 519 in 2021
                   7,199,000,000                                
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,985,676,735; 2021: 1,985,273,421
                   24,429,000,000                                
        common shares held in treasury, at cost — shares: 2022: 234,456,992; 2021: 221,191,228
                   -13,720,000,000                                
        shares: 2022: 1,985,525,053; 2021: 1,982,205,491
                   24,304,000,000                                
        shares: 2022: 151,682; 2021: 347,997
                   10,000,000                                
        shares: 2022: 234,582,764; 2021: 205,385,343
                   -13,726,000,000                                
        shares: 2022: 135,663; 2021: 159,644
                   7,000,000                                
        shares: 2022: 9,891; 2021: 4,510,440
                   -1,000,000                                
        trade receivables, less allowances of 640 in 2022 and 519 in 2021
                    7,179,000,000                               
        ​
                    74,007,000,000 19,364,000,000 73,795,000,000 73,269,000,000 72,785,000,000 18,793,000,000 69,043,000,000 68,776,000,000 66,777,000,000 16,799,000,000 68,539,000,000 68,427,000,000                    
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2022: 1,985,525,053; 2021: 1,985,273,421
                    24,304,000,000                               
        common shares held in treasury, at cost — shares: 2022: 234,582,764; 2021: 221,191,228
                    -13,726,000,000                               
        trade receivables, less allowances of - 2021: 519; 2020: 460
                     6,487,000,000                              
        short-term borrowings
                      197,000,000 199,000,000 199,000,000 213,000,000 208,000,000 205,000,000 204,000,000 201,000,000 204,000,000 204,000,000 201,000,000 211,000,000 341,000,000 230,000,000 211,000,000 218,000,000 207,000,000 2,531,000,000 2,892,000,000 2,610,000,000 2,370,000,000 2,867,000,000 2,921,000,000 4,376,000,000 3,953,000,000 4,370,000,000 3,587,830,000 3,650,975,000 5,730,427,000 
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,985,273,421; 2020: 1,981,156,896
                     24,470,000,000                              
        common shares held in treasury, at cost — shares: 2021: 221,191,228; 2020: 209,926,622
                     -11,822,000,000                              
        trade receivables, less allowances of 507 in 2021 and 460 in 2020
                      6,405,000,000                             
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,983,103,854; 2020: 1,981,156,896
                      24,285,000,000                             
        common shares held in treasury, at cost — shares: 2021: 214,816,885; 2020: 209,926,622
                      -10,999,000,000                             
        trade receivables, less allowances of 498 in 2021 and 460 in 2020
                       6,113,000,000                            
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,982,553,488; 2020: 1,981,156,896
                       24,153,000,000                            
        common shares held in treasury, at cost — shares: 2021: 209,736,139; 2020: 209,926,622
                       -10,340,000,000                            
        trade receivables, less allowances of 475 in 2021 and 460 in 2020
                        6,096,000,000                           
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2021: 1,982,205,491; 2020: 1,981,156,896
                        24,023,000,000                           
        common shares held in treasury, at cost — shares: 2021: 205,385,343; 2020: 209,926,622
                        -9,845,000,000                           
        trade receivables, less allowances of — 2020: 460; 2019: 384
                         6,414,000,000                          
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,981,156,896; 2019: 1,976,855,085
                         24,145,000,000                          
        common shares held in treasury, at cost — shares: 2020: 209,926,622; 2019: 214,351,838
                         -10,042,000,000                          
        trade receivables, less allowances of 446 in 2020 and 384 in 2019
                          5,649,000,000                         
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,980,767,223; 2019: 1,976,855,085
                          24,037,000,000                         
        common shares held in treasury, at cost — shares: 2020: 208,405,642; 2019: 214,351,838
                          -9,873,000,000                         
        trade receivables, less allowances of 422 in 2020 and 384 in 2019
                           5,140,000,000                        
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,979,594,379; 2019: 1,976,855,085
                           23,893,000,000                        
        common shares held in treasury, at cost — shares: 2020: 209,064,380; 2019: 214,351,838
                           -9,904,000,000                        
        shares: 2020: 1,978,112,501; 2019: 1,973,472,506
                           23,731,000,000 23,731,000,000                       
        shares: 2020: 1,481,878; 2019: 2,775,623
                           66,000,000                        
        shares: 2020: 1,979,594,379; 2019: 1,976,248,129
                           23,893,000,000                        
        shares: 2020: 209,267,175; 2019: 209,291,244
                           -9,913,000,000 -9,913,000,000                       
        shares: 2020: 212,973; 2019: 441,459
                           10,000,000                        
        shares: 2020: 10,178; 2019: 729
                           -1,000,000                        
        shares: 2020: 209,064,380; 2019: 208,850,514
                           -9,904,000,000                        
        trade receivables, less allowances of 389 in 2020 and 384 in 2019
                            5,292,000,000                       
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2020: 1,978,112,501 ; 2019: 1,976,855,085
                            23,731,000,000                       
        common shares held in treasury, at cost — shares: 2020: 209,267,175 ; 2019: 214,351,838
                            -9,913,000,000                       
        shares: 2020: 1,976,855,085; 2019: 1,971,189,465
                            23,853,000,000                       
        shares: 2020: 1,257,416; 2019: 2,283,041
                            53,000,000                       
        shares: 2020: 214,351,838; 2019: 215,570,043
                            -10,147,000,000                       
        shares: 2020: 5,333,626; 2019: 6,544,927
                            253,000,000                       
        shares: 2020: 248,963; 2019: 266,128
                            -19,000,000                       
        impact of adoption of new accounting standard
                            -5,000,000                       
        trade receivables, less allowances of — 2019: 384; 2018: 314
                             5,425,000,000                      
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2019: 1,976,855,085; 2018: 1,971,189,465
                             23,853,000,000                      
        common shares held in treasury, at cost — shares: 2019: 214,351,838; 2018: 215,570,043
                             -10,147,000,000                      
        trade receivables, less allowances of 354 in 2019 and 314 in 2018
                              5,450,000,000                     
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2019: 1,976,705,285; 2018: 1,971,189,465
                              23,771,000,000                     
        common shares held in treasury, at cost — shares: 2019: 208,249,580; 2018: 215,570,043
                              -9,631,000,000                     
        shares: 2019: 1,976,248,129; 2018: 1,969,575,366
                              23,665,000,000                     
        shares: 2019: 457,156; 2018: 1,015,106
                              18,000,000                     
        shares: 2019: 1,976,705,285; 2018: 1,970,590,472
                              23,771,000,000                     
        shares: 2019: 208,850,514; 2018: 215,256,082
                              -9,659,000,000                     
        shares: 2019: 605,458; 2018: 1,002,519
                              28,000,000                     
        shares: 2019: 4,524; 2018: 3,877
                                                   
        shares: 2019: 208,249,580; 2018: 214,257,440
                              -9,631,000,000                     
        trade receivables, less allowances of 338 in 2019 and 314 in 2018
                               5,548,000,000                    
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount - shares: 2019: 1,976,248,129 ; 2018: 1,971,189,465
                               23,665,000,000                    
        common shares held in treasury, at cost — shares: 2019: 208,850,514 ; 2018: 215,570,043
                               -9,659,000,000                    
        shares: 2019: 1,973,472,506 ; 2018: 1,969,331,007
                               23,461,000,000                    
        shares: 2019: 2,775,623 ; 2018: 244,359
                               111,000,000                    
        shares: 2019: 1,976,248,129 ; 2018: 1,969,575,366
                               23,665,000,000                    
        balance at march 31 shares: 2019: 209,291,244 ; 2018: 216,143,241
                               -9,679,000,000                    
        shares: 2019: 441,459 ; 2018: 891,641
                               21,000,000                    
        shares: 2019: 729 ; 2018: 4,482
                               -1,000,000                    
        shares: 2019: 208,850,514 ; 2018: 215,256,082
                               -9,659,000,000                    
        trade receivables, less allowances of 331 in 2019 and 314 in 2018
                                5,345,000,000                   
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2019: 1,973,472,506; 2018: 1,971,189,465
                                23,461,000,000                   
        common shares held in treasury, at cost — shares: 2019: 209,291,244; 2018: 215,570,043
                                                   
        shares: 2019: 1,971,189,465; 2018: 1,965,908,188
                                23,512,000,000                   
        shares: 2019: 2,283,041; 2018: 3,422,819
                                76,000,000                   
        shares: 2019: 1,973,472,506; 2018: 1,969,331,007
                                23,461,000,000                   
        shares: 2019: 215,570,043; 2018: 222,305,719
                                -9,962,000,000                   
        shares: 2019: 6,544,927; 2018: 6,402,695
                                303,000,000                   
        shares: 2019: 266,128; 2018: 240,217
                                                   
        shares: 2019: 209,291,244; 2018: 216,143,241
                                -9,679,000,000                   
        impact of adoption of new accounting standards
                                                   
        trade receivables, less allowances of 326 in 2018 and 294 in 2017
                                 5,271,000,000                  
        current assets held for disposition
                                 12,000,000 17,000,000 20,000,000    552,000,000 66,000,000 76,000,000 139,000,000 93,000,000 173,000,000 1,100,000,000 252,000,000 249,000,000    
        non-current assets held for disposition
                                 19,000,000 121,000,000 120,000,000 57,000,000   2,779,000,000 2,000,000 2,000,000 2,000,000 2,000,000 3,000,000 2,043,000,000 52,000,000 53,000,000    
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2018: 1,970,590,472; 2017: 1,965,908,188
                                 23,428,000,000                  
        common shares held in treasury, at cost — shares: 2018: 214,257,440; 2017: 222,305,719
                                                   
        cash flow from (used in) operating activities:
                                                   
        adjustments to reconcile net earnings to net cash from operating activities -
                                                   
        depreciation
                                 825,000,000 556,000,000 268,000,000 763,000,000 508,000,000 252,000,000 605,000,000 405,000,000 203,000,000 648,000,000 416,000,000 215,000,000 689,000,000 463,000,000 224,000,000    
        amortization of intangible assets
                                 1,690,000,000 1,146,000,000 584,000,000 1,415,000,000 914,000,000 522,000,000 429,000,000 289,000,000 144,000,000          
        amortization of inventory step-up
                                 32,000,000 32,000,000 32,000,000 840,000,000 822,000,000 392,000,000             
        gain on sale of businesses
                                                   
        trade receivables
                                      30,000,000         82,000,000    
        inventories
                                    39,000,000               
        other
                                 608,000,000 30,000,000 42,000,000 562,000,000 50,000,000 101,000,000 34,000,000 28,000,000  535,000,000 301,000,000 230,000,000 72,000,000 27,000,000 27,000,000    
        net cash from operating activities
                                 4,535,000,000 2,352,000,000 1,108,000,000 3,930,000,000 1,925,000,000 574,000,000 2,033,000,000 816,000,000  2,138,000,000 943,000,000 2,000,000 2,437,000,000 1,236,000,000 336,000,000    
        cash flow from (used in) investing activities:
                                                   
        acquisitions of property and equipment
                                                   
        acquisitions of businesses and technologies, net of cash acquired
                                                   
        proceeds from business dispositions
                                 48,000,000 48,000,000  5,442,000,000 5,471,000,000              
        proceeds from the sale of mylan n.v. shares
                                    1,977,000,000 1,924,000,000 1,685,000,000    2,290,000,000         
        sales (purchases) of other investment securities
                                                   
        net cash (used in) investing activities
                                                   
        cash flow from (used in) financing activities:
                                                   
        net borrowings (repayments) of short-term debt and other
                                 22,000,000 140,000,000                 
        proceeds from issuance of long-term debt
                                 4,011,000,000                  
        repayments of long-term debt
                                                   
        payment of debt issuance costs
                                                   
        payment of contingent consideration
                                                   
        purchases of common shares
                                                   
        proceeds from stock options exercised
                                 244,000,000 170,000,000 137,000,000 275,000,000 186,000,000 129,000,000             
        dividends paid
                                                   
        net cash (used in) financing activities
                                                   
        effect of exchange rate changes on cash and cash equivalents
                                   35,000,000 97,000,000 73,000,000 65,000,000             
        net decrease in cash and cash equivalents
                                                   
        cash and cash equivalents, beginning of year
                                 9,407,000,000 9,407,000,000 9,407,000,000 18,620,000,000 18,620,000,000 18,620,000,000 5,001,000,000 5,001,000,000 5,001,000,000 4,063,000,000 4,063,000,000 4,063,000,000 3,475,000,000 3,475,000,000 3,475,000,000    
        cash and cash equivalents, end of period
                                 7,369,000,000 3,065,000,000 3,857,000,000 11,012,000,000 9,675,000,000 8,706,000,000 2,500,000,000 2,578,000,000 3,334,000,000 3,132,000,000 4,048,000,000 3,226,000,000 3,613,000,000 3,570,000,000 2,060,000,000    
        trade receivables, less allowances of 319 in 2018 and 294 in 2017
                                  5,192,000,000                 
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2018: 1,969,575,366; 2017: 1,965,908,188
                                  23,317,000,000                 
        common shares held in treasury, at cost — shares: 2018: 215,256,082; 2017: 222,305,719
                                                   
        trade receivables, less allowances of 321 in 2018 and 294 in 2017
                                   5,356,000,000                
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2018: 1,969,331,007; 2017: 1,965,908,188
                                   23,223,000,000                
        common shares held in treasury, at cost - shares: 2018: 216,143,241; 2017: 222,305,719
                                                   
        adjustments to reconcile earnings to net cash from operating activities -
                                                   
        proceeds from business disposition
                                      5,472,000,000 25,000,000 25,000,000 25,000,000 230,000,000 230,000,000 230,000,000       
        sales (purchases) of investment securities
                                         446,000,000    3,358,000,000 1,119,000,000     
        net cash from investing activities
                                         226,000,000  37,000,000   633,000,000     
        net proceeds (repayments of) short-term debt and other
                                   6,000,000                
        net cash from financing activities
                                                   
        trade receivables, less allowances of 279 in 2017 and 250 in 2016
                                    4,800,000,000               
        current liabilities held for disposition
                                       597,000,000 361,000,000 360,000,000 356,000,000 292,000,000 301,000,000 721,000,000 242,000,000 169,000,000    
        non-current liabilities held for disposition
                                       60,000,000      96,000,000 1,000,000 1,000,000    
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2017: 1,964,324,771; 2016: 1,707,475,455
                                    23,118,000,000               
        common shares held in treasury, at cost — shares: 2017: 223,724,084; 2016: 234,606,250
                                                   
        impact of currency devaluation
                                       481,000,000 477,000,000 477,000,000          
        mylan n.v. equity investment adjustment
                                       947,000,000            
        net (repayments of) short-term debt and other
                                                   
        trade receivables, less allowances of 265 in 2017 and 250 in 2016
                                     4,633,000,000              
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount — shares: 2017: 1,962,732,172; 2016: 1,707,475,455
                                     23,012,000,000              
        common shares held in treasury, at cost — shares: 2017: 225,288,908; 2016: 234,606,250
                                                   
        trade receivables, less allowances of 263 in 2017 and 250 in 2016
                                      4,510,000,000             
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2017: 1,960,925,194; 2016: 1,707,475,455
                                      22,886,000,000             
        common shares held in treasury, at cost - shares: 2017: 225,653,140; 2016: 234,606,250
                                                   
        trade receivables, less allowances of 284 in 2016 and 337 in 2015
                                       3,320,000,000            
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2016: 1,706,957,661; 2015: 1,702,017,390
                                       12,939,000,000            
        common shares held in treasury, at cost — shares: 2016: 234,648,138; 2015: 229,352,338
                                                   
        gain on sale of discontinued operations
                                                   
        gain on sale of mylan n.v. shares
                                                   
        net (repayments of) proceeds from issuance of short-term debt and other
                                                   
        proceeds from the issuance of long-term debt
                                          2,485,000,000 2,485,000,000 2,485,000,000       
        proceeds from stock options exercised, including income tax benefit
                                       206,000,000 130,000,000 87,000,000 263,000,000 213,000,000 156,000,000 290,000,000 226,000,000 170,000,000    
        trade receivables, less allowances of 347 in 2016 and 337 in 2015
                                        3,567,000,000           
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2016: 1,705,266,590; 2015: 1,702,017,390
                                        12,835,000,000           
        common shares held in treasury, at cost — shares: 2016: 235,271,175; 2015: 229,352,338
                                                   
        gain on sale of mylan shares
                                                   
        proceeds from the sale of mylan shares
                                           2,290,000,000        
        net cash (used in) from investing activities
                                                   
        trade receivables, less allowances of 350 in 2016 and 337 in 2015
                                         3,430,000,000          
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2016: 1,704,495,344; 2015: 1,702,017,390
                                         12,744,000,000          
        common shares held in treasury, at cost - shares: 2016: 235,343,311; 2015: 229,352,338
                                                   
        net cash (used in) from operating activities
                                                   
        trade receivables, less allowances of 358 in 2015 and 310 in 2014
                                          3,460,000,000         
        prepaid expenses, deferred income taxes, and other receivables
                                          3,523,000,000 3,573,000,000 3,859,000,000 4,173,000,000 4,065,000,000 3,977,000,000  4,164,602,000 4,067,462,000 
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2015: 1,700,525,346; 2014: 1,694,929,949
                                          12,641,000,000         
        common shares held in treasury, at cost — shares: 2015: 208,805,455; 2014: 186,894,515
                                                   
        amortization of intangibles
                                          458,000,000 307,000,000 156,000,000 464,000,000 335,000,000 174,000,000    
        (purchases) sales of other investment securities
                                                   
        net (repayments of ) proceeds from issuance of short-term debt and other
                                                   
        contingent and other consideration payments related to business acquisitions
                                                   
        net increase in cash and cash equivalents
                                             138,000,000 95,000,000     
        trade receivables, less allowances of 362 in 2015 and 310 in 2014
                                           3,553,000,000        
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2015: 1,699,703,688; 2014: 1,694,929,949
                                           12,566,000,000        
        common shares held in treasury, at cost - shares: 2015: 209,262,223; 2014: 186,894,515
                                                   
        trade receivables, less allowances of 317 in 2015 and 310 in 2014
                                            3,481,000,000       
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2015: 1,698,124,396; 2014: 1,694,929,949
                                            12,462,000,000       
        common shares held in treasury, at cost - shares: 2015: 209,367,078; 2014: 186,894,515
                                                   
        purchases of investment securities
                                                   
        net (repayments of) proceeds from short-term debt and other
                                                   
        trade receivables, less allowances of 332 in 2014 and 312 in 2013
                                             3,618,000,000      
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2014: 1,692,708,693; 2013: 1,685,827,096
                                             12,207,000,000      
        common shares held in treasury, at cost - shares: 2014: 186,918,107; 2013: 137,728,810
                                                   
        acquisitions of business and technology
                                                   
        proceeds from issuance of short-term debt and other
                                             1,269,000,000 872,000,000 1,213,000,000    
        transfer of cash and cash equivalents to abbvie inc.
                                                   
        trade receivables, less allowances of 354 in 2014 and 312 in 2013
                                              4,056,000,000     
        common shares, without par value authorized - 2,400,000,000 shares issued at stated capital amount - shares: 2014: 1,691,263,815; 2013: 1,685,827,096
                                              12,126,000,000     
        common shares held in treasury, at cost - shares: 2014: 187,564,782; 2013: 137,728,810
                                                   
        trade receivables, less allowances of 324 in 2014 and 312 in 2013
                                               3,883,000,000    
        common shares, without par value authorized - 2,400,000,000 shares
                                                   
        issued at stated capital amount - shares: 2014: 1,689,594,829; 2013: 1,685,827,096
                                               12,032,000,000    
        common shares held in treasury, at cost - shares: 2014: 187,656,291; 2013: 137,728,810
                                                   
        investments, primarily time deposits and certificates of deposit
                                                31,806,000 51,076,000 255,253,000 
        restricted funds, primarily u.s. treasury bills
                                                1,871,807,000 1,870,936,000 1,870,000,000 
        trade receivables, less allowances of 330,469 in 2010 and 311,546 in 2009
                                                6,248,908,000   
        prepaid expenses, deferred income taxes and other receivables
                                                4,167,996,000   
        salaries, wages and commissions and dividends payable
                                                1,693,496,000   
        common shares, without par value authorized — 2,400,000,000 shares issued at stated capital amount - shares: 2010: 1,618,549,245; 2009: 1,612,683,987
                                                8,624,344,000   
        common shares held in treasury, at cost — shares: 2010: 72,733,280; 2009: 61,516,398
                                                   
        total equity
                                                21,482,724,000 19,994,634,000 21,012,340,000 
        trade receivables, less allowances of 304,348 in 2010 and 311,546 in 2009
                                                 6,338,350,000  
        salaries, dividends payable, and other accruals
                                                 6,298,586,000 6,301,954,000 
        preferred shares, one dollar par value authorized - 1,000,000 shares, none issued
                                                   
        issued at stated capital amount -
                                                   
        shares: 2010: 1,617,202,849; 2009: 1,612,683,987
                                                 8,504,865,000  
        common shares held in treasury, at cost -
                                                   
        shares: 2010: 73,174,127; 2009: 61,516,398
                                                   
        trade receivables, less allowances of 315,873 in 2010 and 311,546 in 2009
                                                  6,520,222,000 
        shares: 2010: 1,616,801,616; 2009: 1,612,683,987
                                                  8,413,595,000 
        shares: 2010: 73,236,557; 2009: 61,516,398
                                                   
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 
                                                               
          cash flow from operating activities:
                                                               
          net earnings
        1,776,000,000 1,644,000,000 1,779,000,000 1,325,000,000 9,229,000,000 1,646,000,000 1,302,000,000 1,225,000,000 1,594,000,000 1,436,000,000 1,375,000,000 1,318,000,000 1,033,000,000 1,435,000,000 2,018,000,000 2,447,000,000 1,989,000,000 2,100,000,000 1,189,000,000 1,793,000,000 2,162,000,000 1,232,000,000 537,000,000 564,000,000 1,049,000,000 960,000,000 1,006,000,000 672,000,000 563,000,000 733,000,000 418,000,000 603,000,000 283,000,000 419,000,000 -329,000,000 615,000,000 316,000,000 580,000,000 784,000,000 2,292,000,000 539,000,000 466,000,000 375,000,000 965,733,000 476,055,000 544,661,000 1,942,803,000 1,724,612,000 1,242,124,000 303,181,000 1,942,782,000 863,818,000 890,660,000 1,291,650,000 1,003,015,000 
          adjustments to reconcile earnings to net cash from operating activities —
                                                               
          depreciation
        370,000,000 371,000,000 357,000,000 336,000,000 342,000,000 331,000,000 334,000,000 333,000,000 332,000,000 328,000,000 302,000,000 315,000,000 311,000,000 317,000,000 315,000,000 311,000,000 369,000,000 327,000,000 370,000,000 425,000,000 358,000,000 298,000,000 272,000,000 267,000,000 273,000,000 270,000,000 268,000,000 267,000,000 269,000,000 288,000,000 268,000,000 255,000,000 256,000,000 252,000,000 200,000,000 202,000,000 203,000,000 232,000,000 201,000,000 215,000,000 226,000,000 239,000,000 224,000,000 239,939,000 238,938,000 221,431,000 430,344,000 320,886,000 354,211,000 420,712,000 379,366,000 354,120,000 313,158,000 303,812,000 287,249,000 
          amortization of intangible assets
        422,000,000 420,000,000 420,000,000 420,000,000 465,000,000 470,000,000 471,000,000 472,000,000 481,000,000 496,000,000 498,000,000 491,000,000 496,000,000 498,000,000 507,000,000 512,000,000 514,000,000 520,000,000 504,000,000 509,000,000 508,000,000 510,000,000 553,000,000 561,000,000 483,000,000 484,000,000 483,000,000 486,000,000 544,000,000 562,000,000 584,000,000 501,000,000 392,000,000 522,000,000 140,000,000 145,000,000 144,000,000                363,866,000   
          share-based compensation
        113,000,000 120,000,000 142,000,000 289,000,000 111,000,000 117,000,000 141,000,000 304,000,000 114,000,000 117,000,000 132,000,000 281,000,000 115,000,000 123,000,000 142,000,000 305,000,000 106,000,000 114,000,000 132,000,000 288,000,000 98,000,000 100,000,000 115,000,000 233,000,000 85,000,000 94,000,000 114,000,000 226,000,000 83,000,000 101,000,000 212,000,000 75,000,000 92,000,000 171,000,000 49,000,000 62,000,000 152,000,000 44,000,000 57,000,000 148,000,000 40,000,000 49,000,000 119,000,000 44,758,000 51,548,000 125,746,000 75,608,000 85,785,000 197,342,000 67,838,000 76,457,000 175,808,000 72,146,000 84,224,000 173,866,000 
          investing and financing losses
                                                               
          trade receivables
        222,000,000 -202,000,000 -410,000,000 -262,000,000 -158,000,000 -57,000,000 -325,000,000 -151,000,000 68,000,000 -461,000,000 -196,000,000 233,000,000 341,000,000 530,000,000 -188,000,000 -751,000,000 -189,000,000 -394,000,000 35,000,000 165,000,000 -581,000,000 -470,000,000 231,000,000 -104,000,000 82,000,000 -22,000,000        30,000,000         82,000,000    -54,220,000 611,030,000 132,482,000 -243,358,000 216,935,000 298,953,000 230,374,000 -45,803,000 291,638,000 
          inventories
        234,000,000 213,000,000 3,000,000 -255,000,000 235,000,000 220,000,000 -103,000,000 -410,000,000 295,000,000 140,000,000 -248,000,000 -419,000,000 -189,000,000 -194,000,000 -476,000,000 -554,000,000 15,000,000 71,000,000 -5,000,000 -537,000,000 345,000,000 149,000,000 -550,000,000 -437,000,000 137,000,000 -190,000,000                        -2,458,000 5,195,000 44,784,000    
          prepaid expenses and other assets
                                                               
          trade accounts payable and other liabilities
                                                               
          income taxes
                                                               
          net cash from operating activities
        3,315,000,000 2,787,000,000 2,047,000,000 1,417,000,000 2,868,000,000 2,705,000,000 1,960,000,000 1,025,000,000 3,038,000,000 1,877,000,000 1,203,000,000 1,143,000,000 2,326,000,000 2,780,000,000 2,410,000,000 2,065,000,000 3,067,000,000 2,701,000,000 2,128,000,000 2,637,000,000 3,798,000,000 2,066,000,000 1,322,000,000 715,000,000 2,416,000,000 1,948,000,000 1,060,000,000 712,000,000 2,183,000,000 1,244,000,000 1,108,000,000 2,005,000,000   1,217,000,000   1,195,000,000 941,000,000 2,000,000 1,201,000,000 900,000,000 336,000,000 522,125,000 716,559,000 460,255,000 3,519,502,000 2,066,829,000 2,224,930,000 3,054,430,000 2,503,152,000 2,011,146,000 2,548,413,000 2,348,297,000 1,522,752,000 
          capital expenditures
        -689,000,000 -496,000,000 -502,000,000 -484,000,000 -720,000,000 -556,000,000 -533,000,000 -398,000,000 -755,000,000 -560,000,000 -507,000,000 -380,000,000 -610,000,000 -467,000,000 -379,000,000 -321,000,000 -614,000,000 -461,000,000 -413,000,000 -397,000,000 -679,000,000 -496,000,000 -642,000,000 -360,000,000 -434,000,000 -401,000,000     
          free cash flows
        2,626,000,000 2,291,000,000 1,545,000,000 933,000,000 2,148,000,000 2,149,000,000 1,427,000,000 627,000,000 2,283,000,000 1,317,000,000 696,000,000 763,000,000 1,716,000,000 2,313,000,000 2,031,000,000 1,744,000,000 2,453,000,000 2,240,000,000 1,715,000,000 2,240,000,000 3,119,000,000 1,570,000,000 680,000,000 355,000,000 1,982,000,000 1,547,000,000 1,060,000,000 712,000,000 2,183,000,000 1,244,000,000 1,108,000,000 2,005,000,000   1,217,000,000   1,195,000,000 941,000,000 2,000,000 1,201,000,000 900,000,000 336,000,000 522,125,000 716,559,000 460,255,000 3,519,502,000 2,066,829,000 2,224,930,000 3,054,430,000 2,503,152,000 2,011,146,000 2,548,413,000 2,348,297,000 1,522,752,000 
          cash flow from investing activities:
                                                               
          acquisitions of property and equipment
        -689,000,000 -496,000,000 -502,000,000 -484,000,000 -720,000,000 -556,000,000 -533,000,000 -398,000,000 -755,000,000 -560,000,000 -507,000,000 -380,000,000 -610,000,000 -467,000,000 -379,000,000 -321,000,000 -614,000,000 -461,000,000 -413,000,000 -397,000,000 -679,000,000 -496,000,000 -642,000,000 -360,000,000 -434,000,000 -401,000,000                              
          acquisitions of businesses and technologies, net of cash acquired
        -20,000,000 -55,000,000       -51,000,000       -172,000,000 -15,000,000 -10,000,000   1,000,000 -11,000,000                              
          proceeds from business dispositions
                  86,000,000   10,000,000       -29,000,000                        
          purchases of investment securities
                                                               
          proceeds from sales of investment securities
                                                              874,139,000 
          other
        477,000,000 221,000,000 -244,000,000 -436,000,000 639,000,000 -22,000,000 140,000,000 -748,000,000 1,937,000,000 -179,000,000 -660,000,000 -1,076,000,000 64,000,000 71,000,000 92,000,000 -205,000,000 166,000,000 -37,000,000 -97,000,000 -6,000,000 -23,000,000 247,000,000 164,000,000 -369,000,000 550,000,000 352,000,000 -890,000,000 15,000,000 578,000,000 -12,000,000 42,000,000 512,000,000 -51,000,000 101,000,000 6,000,000   234,000,000 71,000,000 230,000,000 45,000,000 27,000,000    -10,310,000 1,159,000 11,149,000 1,138,458,000 4,566,000 7,804,000    
          net cash from investing activities
        -913,000,000 -457,000,000 -582,000,000 -470,000,000 -866,000,000 -594,000,000 -453,000,000 -425,000,000 -824,000,000 -634,000,000 -1,213,000,000 -462,000,000 -632,000,000 -484,000,000 -264,000,000 -360,000,000 -671,000,000 -651,000,000 -264,000,000 -422,000,000 -731,000,000 -472,000,000                                  
          cash flow from financing activities:
                                                               
          proceeds from issuance of (repayments of) short-term debt, net and other
                                                               
          proceeds from issuance of long-term debt and debt with maturities over 3 months
                                                               
          repayments of long-term debt and debt with maturities over 3 months
                                                               
          purchases of common shares
        -302,000,000 -305,000,000 -6,000,000 -280,000,000 -315,000,000 -751,000,000 -3,000,000 -226,000,000 -259,000,000 -2,000,000 -426,000,000 -540,000,000 -685,000,000 -798,000,000 -5,000,000 -2,307,000,000 -974,000,000 -579,000,000 -471,000,000 -275,000,000 -161,000,000 -2,000,000 -4,000,000 -236,000,000 -496,000,000 -1,000,000                              
          proceeds from stock options exercised
        5,000,000 69,000,000 35,000,000 287,000,000 25,000,000 92,000,000 13,000,000 134,000,000 34,000,000 56,000,000 15,000,000 62,000,000 41,000,000 57,000,000 10,000,000 59,000,000 82,000,000 70,000,000 17,000,000 86,000,000 16,000,000 83,000,000 57,000,000 89,000,000 7,000,000 47,000,000 117,000,000 127,000,000 74,000,000 33,000,000 137,000,000 89,000,000 57,000,000 129,000,000                      
          dividends paid
        -1,030,000,000 -1,031,000,000 -1,029,000,000 -1,026,000,000 -958,000,000 -960,000,000 -961,000,000 -957,000,000 -888,000,000 -888,000,000 -890,000,000 -890,000,000 -823,000,000 -826,000,000 -828,000,000 -832,000,000 -798,000,000 -801,000,000 -803,000,000 -800,000,000 -641,000,000 -639,000,000 -642,000,000 -638,000,000 -568,000,000 -569,000,000                              
          net cash from financing activities
        -1,397,000,000 -1,760,000,000 -1,097,000,000 -2,055,000,000 -1,861,000,000 -1,576,000,000 -791,000,000 -1,176,000,000 -2,052,000,000 -2,340,000,000 -1,289,000,000 -1,410,000,000 -1,457,000,000 -1,543,000,000 -813,000,000 -3,823,000,000 -1,886,000,000 -1,377,000,000   -787,000,000 -1,915,000,000                                  
          effect of exchange rate changes on cash and cash equivalents
        6,000,000 -10,000,000 51,000,000 24,000,000 -83,000,000 36,000,000 -13,000,000 -36,000,000 25,000,000 -29,000,000 -27,000,000 8,000,000 51,000,000 -96,000,000 -71,000,000 -6,000,000 -13,000,000 -29,000,000 4,000,000 -32,000,000 78,000,000 38,000,000 25,000,000 -70,000,000 27,000,000 -49,000,000 2,000,000 4,000,000   35,000,000 24,000,000 8,000,000 65,000,000               34,700,000  14,298,000 66,203,000    
          net increase in cash and cash equivalents
        1,011,000,000 560,000,000 419,000,000 -1,084,000,000 58,000,000 571,000,000 703,000,000 -612,000,000 187,000,000 -1,126,000,000 -1,326,000,000 -721,000,000 288,000,000 657,000,000 1,262,000,000 -2,124,000,000 497,000,000 644,000,000 604,000,000 1,216,000,000 2,358,000,000 -283,000,000   -231,000,000                43,000,000      944,172,000   972,281,000      
          cash and cash equivalents, beginning of year
        7,616,000,000 6,896,000,000 9,882,000,000 9,799,000,000 6,838,000,000 3,860,000,000 3,844,000,000 9,407,000,000 18,620,000,000 5,001,000,000 4,063,000,000 3,475,000,000 10,802,163,000 6,812,820,000 3,648,371,000 8,809,339,000 
          cash and cash equivalents, end of year
                                                               
          supplemental cash flow information:
                                                               
          income taxes paid
                                                               
          interest paid
                                                               
          adjustments to reconcile net earnings to net cash from operating activities —
                                                               
          sales (purchases) of other investment securities
         90,000,000 -52,000,000 8,000,000  -40,000,000 77,000,000 -28,000,000  -38,000,000 79,000,000 -86,000,000  -21,000,000 59,000,000 -41,000,000  -108,000,000 95,000,000 -14,000,000  17,000,000 4,000,000 -36,000,000  -24,000,000 2,000,000                            
          net borrowings (repayments) of short-term debt and other
         8,000,000 -16,000,000 -36,000,000  44,000,000 -43,000,000 -127,000,000  -61,000,000 13,000,000 -42,000,000  24,000,000 5,000,000 8,000,000  -27,000,000 -4,000,000 24,000,000  -28,000,000 -20,000,000 51,000,000  12,000,000 27,000,000 13,000,000 -118,000,000                           
          proceeds from issuance of long-term debt
         2,000,000 1,000,000  1,000,000       1,000,000        1,000,000                                 
          repayments of long-term debt
         -501,000,000 -1,000,000 -1,001,000,000  -2,000,000    -1,445,000,000    -1,000,000 -1,000,000 -751,000,000  -40,000,000 -3,000,000 -2,000,000  -1,330,000,000 -1,000,000 -1,000,000  -2,000,000                              
          cash and cash equivalents, end of period
         560,000,000 419,000,000 6,532,000,000  571,000,000 703,000,000 6,284,000,000  -1,126,000,000 -1,326,000,000 9,161,000,000  657,000,000 1,262,000,000 7,675,000,000  644,000,000 604,000,000 8,054,000,000  -283,000,000 1,386,000,000 3,377,000,000  954,000,000 115,000,000 3,022,000,000 4,304,000,000 -792,000,000 3,857,000,000 1,337,000,000 969,000,000 8,706,000,000 -78,000,000 -756,000,000 3,334,000,000 -916,000,000 822,000,000 3,226,000,000 43,000,000 1,510,000,000 2,060,000,000 -2,689,800,000 1,199,134,000 4,373,120,000 944,172,000 2,706,866,000 4,345,910,000 972,281,000 1,336,862,000 2,740,156,000 -503,557,000 2,754,882,000 1,566,820,000 
          loss on extinguishment of debt
                                                               
          adjustments to reconcile net earnings to net cash from operating activities-
                                                               
          net cash (used in) financing activities
                           -967,000,000    -735,000,000  -513,000,000                              
          adjustments to reconcile earnings to net cash from operating activities -
                                                               
          amortization of inventory step-up
                                    32,000,000 18,000,000 430,000,000 392,000,000                      
          adjustments to reconcile net earnings to net cash from operating activities -
                                                               
          cash flow from (used in) operating activities:
                                                               
          ​
                                                               
          cash flow from (used in) investing activities:
                                                               
          net cash (used in) investing activities
                               -393,000,000  -432,000,000                              
          cash flow from (used in) financing activities:
                                                               
          net decrease in cash and cash equivalents
                               -483,000,000                                
          amortization of bridge financing fees
                                                               
          gains on sale of businesses
                                                               
          gain on sale of mylan n.v. shares
                                                               
          proceeds from the sale of mylan n.v. shares
                                       53,000,000 239,000,000 1,685,000,000                      
          purchase of alere preferred stock
                                                               
          acquisition and contingent consideration payments related to business acquisitions
                                                               
          gain on sale of businesses
                                                               
          payment of debt issuance costs
                                                               
          payment of contingent consideration
                                                               
          proceeds from business disposition
                                         5,472,000,000 25,000,000 230,000,000                
          sales (purchases) of investment securities
                                            446,000,000    2,239,000,000               
          net proceeds (repayments of) short-term debt and other
                                      6,000,000                         
          impact of currency devaluation
                                          4,000,000 477,000,000                   
          mylan n.v. equity investment adjustment
                                                               
          net (repayments of) short-term debt and other
                                                               
          net cash from (used in) operating activities
                                         574,000,000                      
          net cash from (used in) investing activities
                                            226,000,000                   
          gain on sale of discontinued operations
                                                               
          net (repayments of) proceeds from issuance of short-term debt and other
                                                               
          proceeds from the issuance of long-term debt
                                             2,485,000,000                
          proceeds from stock options exercised, including income tax benefit
                                          76,000,000 43,000,000 87,000,000 50,000,000 57,000,000 156,000,000 64,000,000 56,000,000 170,000,000 37,656,000 73,641,000 68,963,000 524,093,000 359,039,000 687,279,000 47,808,000 93,903,000 175,752,000   188,169,000 
          gain on sale of mylan shares
                                                               
          proceeds from the sale of mylan shares
                                                               
          net cash (used in) from investing activities
                                                               
          net cash (used in) from operating activities
                                                               
          amortization of intangibles
                                             151,000,000 151,000,000 156,000,000 129,000,000 161,000,000 174,000,000 196,753,000 196,892,000 199,422,000 329,384,000 370,549,000 389,056,000 417,674,000 432,046,000 391,547,000   275,252,000 
          (purchases) sales of other investment securities
                                                               
          net (repayments of ) proceeds from issuance of short-term debt and other
                                                               
          contingent and other consideration payments related to business acquisitions
                                                               
          net increase (decrease) in cash and cash equivalents
                                                               
          net (repayments of) proceeds from short-term debt and other
                                                               
          acquisitions of business and technology
                                                               
          proceeds from issuance of short-term debt and other
                                                397,000,000 -341,000,000 1,213,000,000 374,281,000 901,226,000 2,248,631,000  1,297,740,000 1,399,029,000   396,213,000   775,006,000 
          transfer of cash and cash equivalents to abbvie inc.
                                                               
          acquired in-process and collaborations research and development
                                                      110,000,000 150,000,000       
          acquisitions of businesses and technology
                                                               
          payment of long-term debt
                                                               
          contingent consideration payment related to a business acquisition
                                                               
          net cash (used in) from financing activities
                                                               
          acquisition of businesses and technology
                                                               
          release of restricted funds
                                                               
          proceeds from issuance of (repayments of) short-term debt and other
                                                               
          net cash from (used in) financing activities
                                                        286,074,000       
          acquired in-process research and development
                                                         172,500,000 100,000,000    
          (purchases of) proceeds from sales of investment securities
                                                               
          release of (deposit of) restricted funds
                                                              
          repayments of short-term debt and other
                                                               
          acquisitions of businesses, net of cash acquired
                                                               
          deposit of restricted funds
                                                               
          net (decrease) in cash and cash equivalents
                                                               
          derecognition of a contingent liability associated with the conclusion of the tap pharmaceutical products inc. joint venture
                                                               
          proceeds from sales of (purchases of) investment securities
                                                            14,317,000   
          (repayments of) proceeds from issuance of short-term debt and other
                                                               
          payments of long-term debt
                                                               
          proceeds from stock options exercised, including tax benefit
                                                            68,457,000